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A B S T R A C T
Background
Self-management education may help patients with cystic fibrosis and their families to choose, monitor and adjust treatment require-
ments for their illness, and also to manage the effects of illness on their lives. Although self-management education interventions
have been developed for cystic fibrosis, no previous systematic review of the evidence of effectiveness of these interventions has been
conducted.
Objectives
To assess the effects of self-management education interventions on improving health outcomes for patients with cystic fibrosis and
their caregivers
Search methods
We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register (date of the last search: 22 August 2013).
We also searched databases through EBSCO (CINAHL; Psychological and Behavioural Sciences Collection; PsychInfo; SocINDEX)
and Elsevier (Embase) and handsearched relevant journals and conference proceedings (date of the last searches: 01 February 2014 ).
Selection criteria
Randomised controlled trials, quasi-randomised controlled trials or controlled clinical trials comparing different types of self-manage-
ment education for cystic fibrosis or comparing self-management education with standard care or no intervention.
Data collection and analysis
Two authors assessed trial eligibility and risk of bias. Three authors extracted data.
Main results
Four trials (involving a total of 269 participants) were included. The participants were children with cystic fibrosis and their parents
or caregivers in three trials and adults with cystic fibrosis in one trial. The trials compared four different self-management education
interventions versus standard treatment: (1) a training programme for managing cystic fibrosis in general; (2) education specific to
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aerosol and airway clearance treatments; (3) disease-specific nutrition education; and (4) general and disease-specific nutrition education.
Training children to manage cystic fibrosis in general had no statistically significant effects on weight after six to eight weeks, mean
difference -7.74 lb (i.e. 3.51 kg) (95% confidence interval -35.18 to 19.70). General and disease-specific nutrition education for adults
had no statistically significant effects on: pulmonary function (forced expiratory volume at one second), mean difference -5.00 %
(95% confidence interval -18.10 to 8.10) at six months and mean difference -5.50 % (95% confidence interval -18.46 to 7.46) at 12
months; or weight, mean difference - 0.70 kg (95% confidence interval -6.58 to 5.18) at six months and mean difference -0.70 kg (95%
confidence interval -6.62 to 5.22) at 12 months; or dietary fat intake scores, mean difference 1.60 (85% confidence interval -2.90 to
6.10) at six months and mean difference 0.20 (95% confidence interval -4.08 to 4.48) at 12 months. There is some limited evidence
to suggest that self-management education may improve knowledge in patients with cystic fibrosis but not in parents or caregivers.
There is also some limited evidence to suggest that self-management education may result in positively changing a small number of
behaviours in both patients and caregivers.
Authors’ conclusions
The available evidence from this review is of insufficient quantity and quality to draw any firm conclusions about the effects of self-
management education for cystic fibrosis. Further trials are needed to investigate the effects of self-management education on a range
of clinical and behavioural outcomes in children, adolescents and adults with cystic fibrosis and their caregivers.
P L A I N L A N G U A G E S U M M A R Y
Self-management education for cystic fibrosis
We set out to review the effects of self-management education for cystic fibrosis on a range of health outcomes in individuals of all ages
with cystic fibrosis and their caregivers. Our search for available evidence identified four trials, and all four compared a form of self-
management education to standard treatment. The precise focus of self management differed between trials and included a training
programme for managing cystic fibrosis, education on chest treatments, education on nutrition specific to cystic fibrosis, and education
on general and disease-specific nutrition. Self-management education had no positive effects on lung function, weight, or intake of fatty
food. There is some evidence to suggest that self-management education improves knowledge about cystic fibrosis and its management
in patients with this condition and some self-management behaviours in patients and caregivers. However, due to the small number
of trials in this review, and because of concerns about the quality of these trials, we are unable to reach any firm conclusions about the
effects of self-management education for cystic fibrosis. We recommend that further trials are conducted to evaluate the effects of self-
management education interventions.
B A C K G R O U N D
Description of the condition
Cystic fibrosis (CF) is the most common life-limiting, autosomal
recessively inherited disease in Caucasian populations with an es-
timated incidence of 1 per 3000 births per annum (Walters 2007).
Most individuals are diagnosed in their first year of life and many
countries now have newborn screening programmes. The disease
manifests as pancreatic insufficiency, leading tomalabsorption and
failure to thrive and impaired mucociliary clearance, leading to re-
current chest infections and bronchiectasis. Advances in the treat-
ment of this disease have resulted in a marked increase in survival
rates over the past three decades and individuals can now be ex-
pected to live into their fourth decade (Dodge 2007). Nonethe-
less, CF remains a progressive disease involving a complex regimen
of daily treatment including high fat, high calorie dietary intake,
pancreatic enzyme replacement, vitamin supplementation, chest
physiotherapy, nebulizedmedication, and antibiotic therapy in the
event of respiratory infection. This daily regimen places consid-
erable responsibility on patients and family members (especially
parents of children and adolescents) to implement treatment re-
quirements in an effort to optimise health and slow down disease
progression.
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Description of the intervention
The role that individuals with CF and family members play in the
active management of their care is now seen as important for in-
creasing the likelihood of positive health outcomes (Savage 2007;
Sawicki 2007; Williams 2007). A number of self-management
education interventions for patients with CF and their families,
or both, have been developed since the 1990s (e.g. Bartholomew
1991; Bartholomew 1997; Downs 2006). Self-management can
be described as helping patients and their families to choose, mon-
itor and adjust treatment requirements for their illness, and also
manage the effects of illness on their lives. The aim is to help them
achieve the best possible health, and to fit treatment requirements
into their everyday activities around a flexible management plan.
The role of health care professionals is to support patients and
families in this task (Newman 2004).
How the intervention might work
In order to make a difference, self-management education inter-
ventions should help patients and families to solve problems, set
goals, and then plan changes in the ways they behave, so that they
are motivated to manage their illness in the best possible way to-
ward optimumhealth outcomes (Lorig 2003; Schreurs 2003). Tra-
ditionally, patient education programmes typically provided dis-
ease-specific knowledge aimed at increasing compliance withmed-
ical treatment and healthcare professional advice (Lorig 2002). In
contrast, self-management education interventions should equip
patients and families with knowledge, confidence, and skills to
take responsibility for daily decisions concerning their health and
to take effective control over managing the demands of chronic
illness in ways that are flexible and relevant to their lives (Lorig
2002). Self-management education should work in ways that posi-
tion patients and their families as ’experts’ working in partnership
with health care professionals (Department of Health 2001).
Why it is important to do this review
Although self-management education interventions for patients
with CF or family members, or both, continue to be developed
and advocated, there remains uncertainty over the effects of these
interventions and to date no previous systematic review of the
evidence has been conducted. This is an updated version of a
previously published review (Savage 2011).
O B J E C T I V E S
To assess the effects of self-management education interventions
on improving health outcomes for patients with CF and their
caregivers.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials, quasi-randomised controlled trials
and controlled clinical trials. Both published and unpublished
studies were considered and no language restrictions were applied.
Types of participants
Individuals of all ages with a diagnosis of CF (diagnosed clinically
and by sweat or genetic testing) or family members, or both.
Types of interventions
Self-management education programmes designed to help pa-
tients, of any age group, or family members, or both, to solve
problems, set goals, and to plan how best to manage treatment
requirements of CF in their daily lives. Education programmes
were only included if a focus on self-management was explicitly
specified in the aims of the programme or the content of the pro-
gramme, or both. Programmes involving any structured educa-
tional or instructional approach were considered, e.g. web-based
learning; computer-aided programme; video or audiotapes; writ-
tenmaterials; one-to-one or group educational sessions. The inter-
ventions included, but were not limited to, self-management edu-
cation designed to assist patients or their caregivers or bothwith di-
etary management including pancreatic enzyme replacement and
vitamin supplementation, physiotherapy techniques and exercises;
and medication management.
The following comparisons were considered:
1. a self-management education intervention versus another
self-management educational intervention;
2. a self-management education intervention versus no
intervention;
3. a self-management education intervention versus ’standard
treatment’.
Types of outcome measures
Primary outcomes
1. Pulmonary function (analysed as per cent predicted)
i) forced expiratory volume at one second (FEV1)
ii) forced vital capacity (FVC)
iii) residual volume/total lung capacity (RV/TLC)
iv) forced expiratory flow 25-75% (FEF25−75%)
2. Indices of nutritional health or growth
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i) change in height
ii) change in weight
iii) body mass index (BMI)
iv) z score
v) any other indices of nutritional health
Secondary outcomes
1. Self-management behaviour: any measure of the abilities of
the patient (or family member, or both) to fit treatment
requirements for CF into their everyday activities. For the
purpose of this systematic review, we included measures of self-
management skills (e.g. monitoring symptoms, monitoring
calorie intake, regulating pancreatic enzymes according to fat
content of food, performance of breathing techniques; goal
setting and planning care; communicating about illness or
aspects of care). We also included measures of independence,
self-efficacy, coping, problem solving.
2. Adherence to CF treatment requirements: any measure of
the patient’s or family member’s, or both, adherence including
pill counts, self-report forms, diaries, electronic monitoring,
prescription refill history.
3. Knowledge: any measure of the patient’s or family
member’s, or both, knowledge of CF and its management.
4. Health-related quality of life: generic or disease-specific, or
both; physical, psychological, social, cognitive, school
functioning.
5. Utilisation of health services: e.g. number of acute
hospitalisations, average length of hospital stay, clinic
appointments (scheduled and unscheduled), number of visits to
general practitioner, number of respiratory exacerbations
requiring systemic antibiotics.
Search methods for identification of studies
Electronic searches
We identified relevant trials from theGroup’s Cystic Fibrosis Trials
Register facilitated by the Trials Search co-ordinator using the
terms: *education*OR family/community based support program
OR behaviour.
The Cystic Fibrosis Trials Register is compiled from electronic
searches of the Cochrane Central Register of Controlled Trials
(Clinical Trials) (updated each new issue ofThe Cochrane Library),
quarterly searches of MEDLINE, a search of EMBASE to 1995
and the prospective handsearching of two journals - Pediatric Pul-
monology and the Journal of Cystic Fibrosis. Unpublished work was
identified by searching the book of abstracts of three major cystic
fibrosis conferences: the International Cystic Fibrosis Conference;
the European Cystic Fibrosis Conference and theNorth American
Cystic Fibrosis Conference. For full details of all searching activi-
ties for the register, please see the relevant sections of theCochrane
Cystic Fibrosis and Genetic Disorders Group Module.
Date of the last search of theCochrane Cystic Fibrosis andGenetic
Disorders Group Cystic Fibrosis Trials Register: 22 August 2013.
We also undertook separate searches of the following databases:
CINAHL with full text (EBSCO) (Appendix 1); Psychologi-
cal and Behavioural Sciences Collection (EBSCO) (Appendix
2); PsycINFO (EBSCO) (Appendix 3); SocINDEX (EBSCO)
(Appendix 4); Embase (Elsevier) (Appendix 5). No language re-
strictions were applied to separate searches of databases.
Date of the last search of each of these databases: 01 February
2014.
Searching other resources
Reference lists of relevant trials identified were examined for addi-
tional citations. Specialists in the field and authors of the included
trials were contacted to identify possible unpublished data.
Data collection and analysis
Selection of studies
To identify potentially eligible trials, two authors (ES, PB) inde-
pendently screened the titles and abstracts of all reports gleaned
through the search strategy. Where it was not possible to tell from
the title and abstract whether a study was potentially eligible for
inclusion, the authors retrieved full text copies of the studies. We
applied no language restrictions to our search strategy.We planned
to have any papers written in a foreign language translated prior to
evaluating eligibility for inclusion if this could not be determined
from the title and abstract (if available in the English language),
or if an abstract was not available. We identified one non-Engligh
paper (French) (David 2008). One author (MNiC), who is fluent
in this language, translated this paper. Two authors (ES, PB) in-
dependently read full text copies of all trials appearing to meet the
inclusion criteria to determine their eligibility for inclusion in the
review. We resolved any disagreements by discussion. If resolution
was not possible, we planned to consult the other members of
review team to adjudicate and reach consensus, however, this was
not necessary.
Data extraction and management
For all trials that met the inclusion criteria, one author (ES) ex-
tracted data, two authors (PB, DF) independently cross-checked
these. We resolved discrepancies by discussion. If needed, we
planned to consult the other members of review team to resolve
any disagreements. We used a standardised form adapted from
the checklist of items in Table 7.3a in the Cochrane Handbook for
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Systematic Reviews of Interventions (Higgins 2011a), to extract data
from each trial:
• general information (e.g. title, authors, citation and contact
details);
• methods (trial design, randomisation process and other
concerns about bias, study duration);
• participants (total number and flow of participants through
trial, reasons for attrition, sample size estimations, settings,
severity of illness, age and sex, details on co-morbidity);
• interventions (description of intervention including its
content, mode of delivery, duration, setting, number of groups,
treatment of controls);
• outcomes (primary and secondary outcomes relevant to this
review, measures used, time points of data collection, intention
to treat analysis);
• results (for each outcome - sample size, number of missing
participants, summary data for each intervention group, estimate
of effect, and subgroup analyses);
• miscellaneous (funding source, key conclusions by study
authors, references to other relevant articles).
A third author (DF) cross-checked data on number of participants,
mean scores and standard deviations (SD) entered into RevMan
for each outcome against the data extraction forms and published
records (RevMan 2011). We contacted trial authors for informa-
tion either missing or unclear in published records. Where pos-
sible, we grouped outcome data into those measured at 1 to 6
months, 7 to 12 months, 13 to 18 months, 19 to 24 months and
6 monthly intervals after these time points if applicable.
Assessment of risk of bias in included studies
Two authors (ES, PB) assessed each of the included trials for risk
of bias and disagreements were resolved through discussion with-
out the need to consult other members of the review team. We
assessed the risk of bias using the six specific domain-based evalu-
ation criteria as described in the Cochrane Handbook for System-
atic Reviews of Interventions 5.1 (Higgins 2011b). These were se-
quence generation, allocation concealment, blinding, incomplete
outcome data, selective outcome reporting, and other sources of
bias. For ’other sources of bias’ we assessed efforts at minimizing
cross-contamination bias (i.e. unofficial delivery of any aspect of
the intervention to the ’control’ group) including selecting inter-
vention and control groups from different CF centres, asking par-
ticipants in the ’control’ group not to access or use self-manage-
ment education material from sources such as the Internet, other
CF families, CF organisations; asking participants in intervention
group not to discuss the intervention with others until the end
of the study; asking the control group what information about
managing CF they have accessed during the course of the study.
In evaluating the risk of bias for each of the six domains within
each study included in the review, we made a judgement of ’low
risk’, ’high risk’ or ’unclear risk’ on the following basis:
1. ’low risk’ of bias if the description of a domain indicated
that it was adequately addressed;
2. ’high risk’ of bias if the description of a domain indicated
that it was not adequately addressed;
3. ’unclear risk’ of bias if insufficient detail about a domain
was reported.
Measures of treatment effect
To assess differences between groups, we recorded post-treatment
mean difference (MD) values with 95% confidence intervals (CI)
as our treatment effect measure for continuous variables. For di-
chotomous outcomedata, we planned to assess treatment effects by
calculating risk ratios (RR) with 95% confidence intervals (CIs).
However, the trials included in this review only reported contin-
uous outcome data.
Unit of analysis issues
For longitudinal measurements, we analysed data at each assess-
ment time-point post treatment.
Dealing with missing data
To allow an intention-to-treat analysis, we planned to seek data on
the number of participants with each outcome event, by allocated
treated group, irrespective of adherence and whether or not the
individual was later thought to be ineligible or otherwise excluded
from treatment or follow-up. We contacted primary authors of
trials to clarify data where necessary or to advise on data missing
from published papers. We have listed the authors who replied
to our requests for further information in the Acknowledgements
section.
Assessment of heterogeneity
We planned to pool the results of studies only if they were judged
to be sufficiently similar in terms of populations, interventions
and outcomes. We planned to measure the inconsistency of trial
results using I2 statistic to determine if variation in outcomes across
trials was due to heterogeneity rather than occurring by chance
(Deeks 2011). The I2 statistic quantifies heterogeneity in terms
of overlapping percentage intervals: 0% to 40% (might not be
important); 30% to 60% (may representmoderate heterogeneity);
50% to 90% (may represent substantial heterogeneity); and 75%
to 100% (considerable heterogeneity) (Deeks 2011).
Assessment of reporting biases
We planned to assess funnel plot asymmetry for publication biases
and other causes. However, this was not possible because tests for
funnel plot asymmetry are not recommended unless there are at
least 10 trials included in a meta-analysis (Sterne 2011).
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Data synthesis
If we had identified studies as being clinically (e.g. similar age
groups) or methodologically (e.g. similar interventions) homoge-
nous but statistically heterogeneous, we planned to conduct a
random-effects meta-analysis. However, we did not conduct any
meta-analysis in this review since studies were either clinically or
methodologically diverse (or both). Conducting a meta-analysis
on data from diverse studies runs the risk of obscuring genuine
differences in effect (Deeks 2011). For future updates of this re-
view, we will continue to plan for meta-analysis if appropriate. A
narrative synthesis of the data is currently presented.
Subgroup analysis and investigation of heterogeneity
If we had identified substantial heterogeneity and included a suf-
ficient number of trials, we planned to conduct subgroup analyses
to investigate possible reasons for variations in results across trials.
For subgroup analyses, we planned to make comparisons between
subsets of participants, subsets of interventions, subsets of settings
in which interventions were delivered, and subsets of personnel
delivering interventions. We planned to stratify studies into:
1. participant age-group subsets (infants and toddlers up to
two years, pre-school children aged 2 years to 5 years, primary
school children aged 6 years to 12 years, adolescents aged 13
years to 17 years, adults aged 18 years and over);
2. intervention type (e.g. web-based learning, computer-aided
programme, written materials, etc) and duration;
3. settings in which intervention was conducted (e.g. home,
hospital, school);
4. personnel delivering intervention (e.g. dietitians, nurses,
physicians, physiotherapists, CF advocacy or voluntary groups).
In future updates of this review, we will continue to adopt this
plan for subgroup analysis and investigation of heterogeneity.
Sensitivity analysis
If appropriate, we planned to conduct sensitivity analysis to deter-
mine the influence on effect size of: published and unpublished
trials; risk of bias as outlined above; length and size of studies.
However, there were insufficient studies to perform this analysis.
R E S U L T S
Description of studies
Results of the search
A total of 208 recordswere identified through our search strategy as
potentially relevant for inclusion. Of these, 62 citations reporting
on 34 studies were identified by a search of the Cystic Fibrosis and
Genetic Disorders Group’s CF Trials Register. An additional 145
records were identified from our search of individual databases.
One additional record was identified in a newsletter published in
Cystic Fibrosis Worldwide.Of the 208 records examined, a total of
11 records reporting on four trials were identified as meeting the
inclusion criteria (Cottrell 1996; Downs 2006; Stapleton 2001;
Watson 2008). Eightadditional records (on six studies) were iden-
tified as potentially eligible for inclusion and are awaiting clas-
sification (Bergman 2007; Cannon 1999; Jessup 2008; Johnson
2001; Van der Gieesen 2006; Wainwright 2009). One record was
identified as of an ongoing trial (Huang 2009). The remaining
186 records were excluded.
Included studies
The four included trials were published in peer-reviewed jour-
nals (Cottrell 1996; Downs 2006; Stapleton 2001;Watson 2008).
Multiple records for three of the trials were identified: one was re-
ported in three journal articles (Stapleton 2001); one was reported
in four conference proceeding abstracts and one journal article
(Watson 2008); and one was reported in an unpublished thesis
and in a journal article (Cottrell 1996). For multiple records, data
were extracted from the most recent publication and then from
earlier publications as necessary.
Trial design
All four trials were of parallel design. Three trials were conducted
in a single centre (Cottrell 1996; Stapleton 2001; Watson 2008).
One trial was multicentre involving CF clinics of three public
hospitals (Downs 2006).Two trials were undertaken in Australia
(Downs 2006; Stapleton 2001); one in the USA (Cottrell 1996)
and one in the UK (Watson 2008).
Participants
A total of 368 participants were recruited and randomised across
the four trials: 139 children with CF; 155 caregivers of children;
and 74 adults with CF. A total of 269 participants completed
the trials: 104 children; 117 parents/carergivers (Cottrell 1996;
Downs 2006; Stapleton 2001); and 48 adults (Watson 2008).
1. Children
Children with CF were included in three trials, aged 8 years to 18
years in one trial (Cottrell 1996), and 6 years to 11 years in two
trials (Downs 2006; Stapleton 2001).
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2. Caregivers/parents
Caregivers of children were included in three trials (Cottrell 1996;
Downs 2006; Stapleton 2001). Caregivers were explicitly stated as
parents in one trial (Cottrell 1996) and as the adult most respon-
sible for managing children’s nutrition in another trial (Stapleton
2001). It was not explicitly stated who the caregivers were in one
trial (Downs 2006).
3. Adults
Adults with CF were aged 16 years to 43 years. None of the adults
were waiting on a “heart/lung transplant list or were pregnant or
lactating” at the time of taking part in the trial (Watson 2008).
Interventions
1. A self-management education intervention versus another
self-management educational intervention
No included trial made this comparison.
2. A self-management education intervention versus no
intervention
No included trial made this comparison.
3. A self-management education intervention versus
’standard treatment’
The four included trials made this comparison.
a. Self-management training programme versus standard
treatment
One trial evaluated the effects of a self-management training pro-
gramme in reducing the impact of CF on children and parents
(Cottrell 1996). The programme was delivered in two six-hour
group sessions in a hospital setting, facilitated by a registered nurse
or psychologist. In the group sessions, knowledge of the nature
of CF, principles of self-management, and strategies for manag-
ing CF-related problems were addressed. Skills training included
problem solving and stress management.
b. Self-management education on aerosol and airway
clearance treatments (’Airways’) versus standard treatment
One trial evaluated the effects of an education programme (’Air-
ways’) on the self-management of aerosol and airway clearance
treatments (Downs 2006). The ‘Airways’ programme was home
based using writtenmaterial containing child friendly information
and behavioural exercises. Over a period of 10 weeks, children and
their caregivers completed weekly exercises, each lasting approx-
imately 20 minutes. The knowledge content of the programme
drew on disciplines of medicine, physiotherapy, psychology and
education. Self-management skills addressed in the programme
were assessment, treatment implementation, decisionmaking, and
strategies to overcome barriers to treatment.
c. Nutrition self-management education versus standard
treatment
Two trials made this comparison focusing on either disease-spe-
cific nutrition education (Stapleton 2001) or general and disease-
specific nutrition education (Watson 2008).
i. Sub-comparison: Disease-specific nutrition education (’Go and
Grow with CF’) versus standard treatment
One trial evaluated the effects of a nutrition education programme
(’Go and Grow with CF’) on disease-specific nutrition knowl-
edge and self-management skills (Stapleton 2001). The ’Go and
Grow with CF’ programme was home based using child-friendly
written material on nutrition management. Over a period of 10
weeks, children and their caregivers completed weekly exercises,
each lasting approximately 60 minutes. The programme included
supplementary introductory and concluding workshops for sep-
arate groups of children and caregivers in a hospital setting, fa-
cilitated by dietitians. Knowledge content of the programme in-
cluded disease-specific nutrition topics: enzymes; energy and fat;
malabsorption; vitamins and minerals; growth; snacks; and salt.
Self-management skills addressed in the programme were goal set-
ting in small incremental steps to increase self efficacy, and self-
monitoring adherence to daily goals.
ii. Sub-comparison: General and disease-specific nutrition educa-
tion (’Eat Well with CF’) versus standard treatment
One trial evaluated the effects of a nutrition education programme
(’EatWell withCF’) on general anddisease-specific knowledge and
self-management skills training (Watson 2008). The ’Eat Well for
CF’ programme was home-based using written materials. Over a
period of 10 weeks, participants completed weekly activities, each
lasting approximately 30 minutes. Knowledge content of the pro-
gramme included general and disease-specific nutrition topics: en-
ergy intake; digestion; pancreatic enzyme replacement; managing
appetite; exercise; dietary fibre; reading food labels; body image.
Self-management skills included goal setting in small incremental
steps to establish new behaviours.The programme included sup-
plementary group workshops (introductory weeks 5 and 10) in
a hospital setting and weekly telephone calls, facilitated by dieti-
tians. During the course of the trial, microbiological segregation
was introduced following which workshops could no longer be
held. Consequently, the trial was terminated.
Outcomes
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Only outcomes of trials comparing ’Self-management education
intervention versus standard treatment’ are reported since no trials
were identified for the remaining two comparisons groups consid-
ered in this review.
3. Self-management education intervention versus ’standard
treatment’
a. Self-management training programme versus standard
treatment
In the one trial that made this comparison, one primary and four
secondary outcomes relevant to this review were assessed (Cottrell
1996). Only our pre-defined outcomes that were reported in the
included trials are listed below.
Primary outcomes
2. Indices of nutritional health or growth
Change in weight was measured in pounds using participants’
home scales (Cottrell 1996).
Secondary outcomes
1. Self-management behaviour
The number and frequency of both children’s and parent’s be-
haviours in relation to managing digestive and pulmonary system
problem areas were assessed using previously established question-
naires. The number of self-management behaviours thatwere done
’at least sometimes’ were recorded out of a total of 21 digestive
system problem areas and a total of 26 pulmonary system problem
areas. The maximum total score for self-management behaviour
was 47. For each of the 47 self-management behaviours, frequency
of performance was rated on a four-point scale ranging from 0 =
never to 4 = always. An average of the response scores provided
an overall frequency score ranging between zero and four (Cottrell
1996).
2. Adherence
Medications and aerosol treatment taken by children as well as the
number of chest physiotherapy sessions were assessed using a self-
report diary. It was unclear whether children or parents completed
the diary. Percentage ’compliance’ was computed for each aspect of
treatment by comparing reported ’compliance’ with the schedule
prescribed by physicians (Cottrell 1996).
3. Knowledge
Knowledge was assessed using an established ‘CF Knowledge Sur-
vey’ consisting of multiple-choice questions for children, adoles-
cents, and parents. The percentage of correct answers from each
participant was recorded (Cottrell 1996).
4. Health-related quality of life
Children’s quality of life was measured using the ‘quality of well-
being scale’ comprising three sub scales of functioning (mobility,
physical activity, social activity) and twenty two problems/symp-
toms that could impair function. The total quality of life score
ranged from zero (dead) to one (optimal functioning) (Cottrell
1996).
All outcomes were assessed at baseline and at six- to eight-week
follow-up. Results for all outcomes were expressed as means and
SDs (Cottrell 1996).
b. Self-management education on aerosol and airway
clearance treatments (’Airways’) versus standard treatment
In the one trial that made this comparison, three secondary out-
comes relevant to this review were assessed (Downs 2006).
Secondary outcomes
1. Self-management behaviours
Self-management behaviours of caregivers relating to aerosol and
airway clearance treatments were assessed. Caregivers completed
a newly developed one-week diary card constructed around three
self-management sub scales: assessment; treatment; and commu-
nication. The unit of measure was a fractional score with one being
the best possible score (Downs 2006).
Self-management responsiveness of caregivers to airway clearance
treatment during children’s unwell days was recorded. The per-
formance of longer and additional airway clearance treatment was
considered to be responsive to the child’s treatment needs. A mean
responsiveness score for all unwell days was calculated (Downs
2006).
Self-efficacy of caregivers to manage airway clearance treatments
was assessed using an established ‘self-efficacy scale’ with five being
the best possible score (Downs 2006).
2. Adherence
Adherence to aerosol and airway clearance treatment was reported
by caregivers in a one-week diary and was measured as a percentage
of prescribed treatments taken by children (Downs 2006).
3. Knowledge
Children’s knowledge on airway clearance treatment was assessed
using a newly developed questionnaire with 23 being the best
possible score (Downs 2006).
In this trial, adherence, self-management behaviours (assessment,
treatment, communication) and self-efficacy were assessed at base-
line, at immediate post test, and at 6- and 12-month follow-up.
Self-management responsiveness was assessed at baseline and at
post test. Knowledge was assessed at baseline, post test and at 12-
month follow-up. Results for all outcomeswere expressed asmeans
and SDs (Downs 2006).
c. Nutrition self-management education versus standard
treatment
i. sub-comparison: Disease-specific nutrition education (’Go and
Grow with CF’) versus standard treatment
In the one trial that made this sub-comparison, two secondary
outcomes relevant to this review were assessed (Stapleton 2001).
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Secondary outcomes
1. Self-management behaviours
Self-management skills of both children and caregivers were as-
sessed using scenarios designed to yield open responses categorised
as appropriate or inappropriate. For children, scenarios related to
signs of malabsorption and communicating to caregivers about
nutritional management; the highest possible scores being 23 for
appropriate responses and five for inappropriate responses. For
caregivers, scenarios related to malabsorption and assessment of
what age they expected their children to manage their own pan-
creatic enzyme replacement therapy. The highest possible scores
for caregivers were 61 for appropriate responses and 41 for inap-
propriate responses (Stapleton 2001).
3. Knowledge
Nutritional and enzyme knowledge was assessed using similar but
separate newly developed questionnaires for children and care-
givers. Each correct response was allocated a score of one. For
children, the best possible score was 37. For caregivers, the best
possible score was 42 (Stapleton 2001).
All outcomes in this trial were assessed at baseline, at immediate
post-test, and at 12 month follow-up. Results for all outcomes
were reported as mean score change and standard error (SE) values
from baseline (Stapleton 2001). On request, the author provided
unpublished data on mean differences and SEs for intervention
effects.
ii. sub-comparison: General and disease-specific nutrition education
(’Eat Well with CF’) versus standard treatment
In the one trial that made this sub-comparison, two primary out-
comes and three secondary outcomes relevant to this review were
assessed (Watson 2008).
Primary outcomes
1. Pulmonary function
Watson assessed FEV1 analysed as per cent predicted (Watson
2008).
2. Indices of nutritional health or growth
Change inweight was assessed in kilograms using the samemedical
weighing scale for all participants (Watson 2008).
Dietary fat intake was assessed using a 17-item self-reported food
frequency questionnaire, yielding a maximum score of sixty three
points as the best possible score (Watson 2008).
Secondary outcomes
1. Self-management behaviour
Self-efficacy of adults to cope with a special diet was assessed using
a newly developed measure, with 27 being the best possible score
(Watson 2008).
3. Knowledge
Disease-specific and general nutrition knowledge were assessed us-
ing separate questionnaires adapted from previously established
questionnaires designed for adults; the highest possible scores be-
ing 55 for disease-specific knowledge and 21 for general knowl-
edge (Watson 2008).
4. Health-related quality of life
Quality of life was assessed using an established disease-specific
measure for adults comprised of nine CF-specific domains (phys-
ical functioning, social functioning, treatment issues, chest symp-
toms, emotional responses, concerns for the future, interpersonal
relationships, body image, career issues). The best possible health-
related quality of life score that could be attained was 100 (Watson
2008).
All outcomes in this trial were assessed at baseline, and at 6- and12-
month follow-up. Results for all outcomeswere expressed asmeans
and SDswith the exception of quality of life, which were presented
as differences in scores for each domain between intervention and
control group (Watson 2008).
Excluded studies
Of the 208 records examined, 140 records were excluded follow-
ing a review of title and abstracts because they were: review pa-
pers; reported on practice initiatives and were not studies; reported
on instrument development; were clearly not education interven-
tions; or did not include participants with CF. An additional 46
records (reporting on 25 studies) were excluded following review
of abstracts and related full text publications because theywere not
RCTs, quasi-RCTs or CCTs or did not explicitly address self-man-
agement education in the aims or content of the programme. De-
tails of the 25 excluded studies are presented in the Characteristics
of excluded studiestable.
Missing data
The principal authors of the four included trials were contacted
for information missing from published records. Missing data in
the four trials related mainly to criteria for assessing risk of bias
Three authors provided additional information (Stapleton 2001;
Downs 2006; Watson 2008). Details of missing data are provided
in the Characteristics of included studies table.
Studies awaiting classification
Six studies await classification, five of which were published as
abstracts (Cannon 1999; Jessup 2008; Johnson 2001; Van der
Gieesen 2006; Wainwright 2009). The remaining study was pub-
lished in the Cystic Fibrosis Worldwide Newsletter targeting a lay
and professional audience (Bergman 2007). All studies are await-
ing classification because insufficient details on characteristics of
the studies are available, and data on outcomes could not be ex-
tracted from publications in the format required for analysis. The
principal authors of five studies have been contacted for further
information (Bergman 2007; Jessup 2008; Johnson 2001; Van der
Gieesen 2006; Wainwright 2009), two of whom have responded
(Johnson 2001; Van der Gieesen 2006). Efforts to locate contact
details on any of the authors concerning one study have failed
(Cannon 1999). Information available to date on the six studies is
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presented in the Characteristics of studies awaiting classification
table.
Risk of bias in included studies
Based on the six domain-based evaluation criteria recommended in
the Cochrane Handbook for Systematic Reviews of Interventions
5.1 (Higgins 2011b), none of the four included trials were judged
as adequately meeting all criteria (Figure 1; Figure 2).
Figure 1. Risk of bias graph: review authors’ judgements about each risk of bias criterion presented as
percentages across all included studies.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias criterion for each
included study.
Please refer to the risk of bias tables for each individual trial located
within the Characteristics of included studies table.
Allocation
Sequence generation was judged to be low risk in three trials (
Downs 2006; Stapleton 2001; Watson 2008) and unclear in one
trial (Cottrell 1996). Allocation concealment was judged to be
unclear in two trials (Cottrell 1996; Stapleton 2001), high risk in
one trial (Downs 2006), and low risk in one trial (Watson 2008).
Blinding
Details on blinding were unclear in the four trials (Cottrell 1996;
Downs 2006; Stapleton 2001; Watson 2008). Blinding of par-
ticipants is not possible for any of the interventions considered,
however in two trials outcome assessors were blinded to at least
some of the outcomes (Downs 2006; Stapleton 2001).
Incomplete outcome data
For incomplete outcome data, one trial was judged to be low risk
(Watson 2008) and unclear in three trials (Cottrell 1996; Downs
2006; Stapleton 2001).
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Selective reporting
One trial was judged to be high risk in terms of being ’free of
selective reporting’ (Stapleton 2001) and unclear in three trials
(Cottrell 1996; Downs 2006; Watson 2008).
Other potential sources of bias
For the criterion on ‘free from other bias’, three trials were deemed
to be low risk (Downs 2006; Stapleton 2001; Watson 2008), and
high risk in one trial (Cottrell 1996).
Effects of interventions
Only the effects of ’a self-management education intervention ver-
sus standard treatment’ are reported since no trials made the re-
maining two comparisons considered in this review. Only our pre-
defined outcomes that have been reported on within the included
trials are listed below. A summary of effects of interventions is
presented in Table 1.
3. A self-management education intervention versus
’standard treatment’
a. Self-management training programme versus standard
treatment
One trial made this comparison (Cottrell 1996).
Primary outcomes
i. Children
2. Indices of nutritional health or growth
At six- to eight-week follow-up, therewas no statistically significant
difference in change in weight between children in the training
group and those in the standard treatment group, MD -7.74 lb
(95% CI -35.18 to 19.70), which in kg, is equivalent to, MD 3.51
kg (95% CI -15.96 to 8.94) (Analysis 1.1).
Secondary outcomes
i. Children
1. Self-management behaviours
a. Number of digestive and pulmonary system behaviours
At the six- to eight- week follow-up, the number of digestive sys-
tem behaviours was significantly greater in the standard treatment
group than training group, MD -5.30 (95% CI -9.29 to -1.31)
(Analysis 1.2).
There was no statistically significant difference between groups in
the number of pulmonary system behaviours, MD -1.00 (95% CI
-6.31 to 4.31) (Analysis 1.3). The mean difference between the
training and the standard treatment groups in the total number of
behaviours performed for both digestive and pulmonary systems
could not be calculated because published data were missing on
the control group.
b. Frequency of digestive and pulmonary system behaviours
At six- to eight-week follow-up, there were no statistically signif-
icant differences between training and standard treatment groups
in the frequency scores on performing behaviours for digestive
system, pulmonary system, or total frequency scores of both sys-
tems combined, MD -0.35 (95% CI -1.05 to 0.35), MD -0.28
(95% CI -0.90 to 0.34), and MD -0.18 (95% CI -0.81 to 0.45)
respectively (Analysis 1.4; Analysis 1.5; Analysis 1.6).
2. Adherence
At six- to eight-week follow-up, there were no statistically sig-
nificant differences between the training and standard treatment
groups in the percentage of prescribed medications, aerosol treat-
ments, and chest physiotherapy taken by children, MD 2.00%
(95% CI -16.31 to 20.31), MD 13.00% (95% CI -20.11 to
46.11), and MD -8.00 % (95% CI -46.13 to 30.13) respectively
(Analysis 1.7; Analysis 1.8; Analysis 1.9).
3. Knowledge
At six- to eight-week follow-up, the percentage of correct answers
on knowledge about CF and its management were significantly
greater in children in the training group than the standard treat-
ment groups, MD 19.25% (95% CI 7.57 to 30.93) (Analysis
1.10).
4. Health-related quality of life
At six- to eight-week follow-up, there was no statistically signifi-
cant difference in children’s quality of well-being scores between
training and standard treatment groups, MD -0.02 (95%CI -0.09
to 0.05) Analysis 1.11).
ii. Parents
1. Self-management behaviours
a. Number of digestive and pulmonary system behaviours
At the six- to eight-week follow-up, there were no statistically
significant differences between training and standard treatment
groups in the number of behaviours performed for digestive sys-
tem, pulmonary system, or total number of behaviours for both
systems combined, MD -1.00 (95% CI -3.47 to 1.47), MD 0.40
(95% CI -2.73 to 3.53), and MD -0.60 (95% CI -5.20 to 4.00)
respectively (Analysis 1.12; Analysis 1.13; Analysis 1.14).
b. Frequency of digestive and pulmonary system behaviours
At six- to eight-week follow-up, there were no statistically signif-
icant differences between training and standard treatment groups
in the frequency scores on performing behaviours for digestive sys-
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tem, pulmonary system, or total frequency of both systems com-
bined, MD -0.09 (95% CI -0.65 to 0.47); MD 0.02 (95% CI -
0.45 to 0.49); and MD 0.00 (95% CI -0.44 to 0.44) respectively
(Analysis 1.15; Analysis 1.16; Analysis 1.17).
3. Knowledge
At the six- to eight-week follow-up, there was no statistically sig-
nificant difference between intervention and control groups in the
percentage of correct knowledge answers about CF and its man-
agement, MD 2.11% (95% CI -6.65 to 10.87) (Analysis 1.18).
b. Self-management education on aerosol and airway
treatment clearance education (’Airways’) versus standard
treatment
One trial made this comparison (Downs 2006).
Secondary outcomes
i. Children
2. Adherence
At post test, the six-month and 12-month follow-up, the percent-
age of prescribed aerosol treatments taken by children was sig-
nificantly greater in the ’Airways’ group than standard treatment
group,MD29.70% (95%CI 14.29 to 45.11), MD 21.00% (95%
CI 5.59 to 36.41), and MD 17.50% (95% CI 5.50 to 29.50) re-
spectively (Analysis 2.1).
At the six-month follow-up, the percentage of prescribed airway
clearance treatments taken by children was significantly greater in
the ’Airways’ group than standard treatment group, MD 21.60%
(CI 95% 7.04 to 36.16). The difference was not statistically sig-
nificant at immediate post test and the 12-month follow-up, MD
19.00% (95% CI -0.62 to 38.62), and MD 15.10% (95% CI -
3.18 to 33.38) respectively (Analysis 2.2).
3. Knowledge
At immediate post test and the 12-month follow-up, children’s
knowledge scores were significantly greater in the ’Airways’ group
than standard treatment group, MD 3.80 (95% CI 2.29 to 5.31),
and MD 4.60 (95% CI 2.83 to 6.37) respectively. This outcome
was not assessed at the six-month follow-up (Analysis 2.3).
ii. Caregivers
1. Self-management behaviours
a. Assessment behaviour
At immediate post test, caregiver assessment behaviour scores were
significantly greater in the ’Airways’ group than standard treatment
group, MD 0.17 (95% CI 0.02 to 0.32). The differences were not
statistically significant at the six-month or 12-month follow-up:
MD 0.15 (95% CI -0.01 to 0.31); and MD 0.08 (95% CI -0.06
to 0.22) respectively (Analysis 2.4).
b. Treatment behaviour
At immediate post test, there was no statistically significant differ-
ence between ’Airways’ and standard treatment groups in caregiver
treatment behaviour scores, MD 0.07 (95% CI -0.01 to 0.15). At
six-month follow-up, caregiver treatment behaviour scores were
significantly greater in the ’Airways’ group than standard treatment
group, MD 0.12 (95% CI 0.06 to 0.18). At 12-month follow-
up, the difference in scores between groups was not statistically
significant, MD 0.04 (95% CI -0.04 to 0.12) (Analysis 2.5).
c. Communication behaviour
At immediate post test and the six-month follow-up, caregiver
communication behaviour scores were significantly greater in the
’Airways’ group than standard treatment group, MD 0.29 (95%
CI 0.13 to, 0.45), and MD 0.20 (95% CI 0.03 to 0.37) respec-
tively. The difference in scores between groups was not statistically
significant at the 12-month follow-up, MD 0.11 (95% CI -0.06
to 0.28) (Analysis 2.6).
d. Responsiveness to airway clearance treatments on children’s un-
well days
At immediate post test, there was no statistically significant dif-
ference between ’Airways’ and standard treatment groups in care-
giver scores for responsiveness to airway clearance treatments on
children’s unwell days, MD 0.23 (95% CI -0.08 to 0.54). This
outcome was not assessed at follow-up time points (Analysis 2.7).
e. Self-efficacy to manage airway clearance treatments
At immediate post test, six-month and 12-month follow-up, there
were no statistically significant differences between intervention
and control groups in caregiver self-efficacy scores,MD0.06 (95%
CI -0.25 to 0.37), MD 0.23 (95% CI -0.08 to 0.54), and MD
0.25 (95% CI -0.00 to 0.50) respectively (Analysis 2.8).
c. Nutrition self-management education versus standard
treatment
i. Sub-comparison: Disease-specific nutrition education (’Go
and Grow with CF’) versus standard treatment
One trial made this sub-comparison (Stapleton 2001).
Secondary outcomes
i. Children
1. Self-management behaviours
Data for analysis in the format required for this review could not
be extracted frompublished records of the trial. These data became
available from the principal author on request.
a. Appropriateness of nutrition and enzyme self-management
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At immediate post test and 12-month follow-up, there were no
statistically significant differences between ’Go and Grow’ and
standard treatment groups in changes in nutrition and enzyme
appropriate self-management response scores, MD 0.60 (95% CI
-1.34 to 2.54), andMD -0.50 (95% CI -2.16 to 1.16) respectively
(Analysis 3.1).
At immediate post test, children’s nutrition and enzyme inappro-
priate self-management response scores were significantly lower in
the ’Go and Grow’ group than standard treatment group, MD
0.80 (95% CI 0.10 to 1.50). The difference was not statistically
significant at the 12-month follow-up, MD 0.40 (95% CI -0.58
to 1.38) (Analysis 3.2).
3. Knowledge
At immediate post test, children’s nutrition knowledge scores were
significantly greater in the ’Go and Grow’ group than standard
treatment group, MD 3.10 (95% CI 0.06 to 6.14). The difference
between groups was not statistically significant at the 12-month
follow-up, MD -0.30 (95% CI -3.56 to 2.96) (Analysis 3.3).
ii. Caregivers
1. Self-management behaviours
a. Appropriateness of nutrition and enzyme self-management
At immediate post test and the 12-month follow-up, there were
no statistically significant differences between ’Go and Grow’ and
standard treatment groups in caregivers nutrition and enzyme ap-
propriate self-management response scores, MD 0.40 (95% CI -
0.98 to 1.78), and MD 0.00 (95% CI -1.68 to 1.68) respectively
(Analysis 3.4).
At immediate post test and the 12-month follow-up, there were
no statistically significant differences between ’Go and Grow’ and
standard treatment groups in caregivers nutrition and enzyme in-
appropriate self-management response scores, MD 0.60 (95% CI
-1.37 to 2.57) and MD -0.80 (95% CI -3.73 to 2.13) respectively
(Analysis 3.5).
3. Knowledge
At immediate post test and the 12-month follow-up, there were
no statistically significant differences between ’Go and Grow’
and standard treatment groups in caregivers’ nutrition knowledge
scores, MD 0.10 (95% CI -1.56 to 1.76), and MD -0.60 (95%
CI -2.13 to 0.93) respectively (Analysis 3.6).
ii. Sub-comparison: General and disease-specific nutrition
education (’Eat Well with CF’) versus standard treatment
One trial made this sub-comparison in adults with CF (Watson
2008).
Primary Outcomes
1. Pulmonary function (analysed as per cent predicted):
a. forced expiratory volume at one second (FEV1)
At the six-month and 12-month follow-up, there were no statisti-
cally significant differences between ’ Eat Well with CF’ and stan-
dard treatment groups in per cent predicted FEV1, MD -5.00 %
(95% CI -18.10 to 8.10), and MD -5.50 % (95% CI -18.46 to
7.46) respectively (Analysis 4.1).
2. Indices of nutritional health or growth
a. Change in weight
At the six-month and 12-month follow-up, there were no statisti-
cally significant differences between ’Eat Well with CF’ and stan-
dard treatment groups in changes in weight, MD - 0.70 kg (95%
C1 -6.58 to 5.18), MD -0.70 kg (95% C1 -6.62 to 5.22) respec-
tively (Analysis 4.2) .
b. Dietary fat intake
At the 6-month and 12-month follow-up, there were no statisti-
cally significant differences between ’Eat Well with CF’ and stan-
dard treatment groups in self-reported dietary fat intake scores,
MD 1.60 (85% C1-2.90 to 6.10), and MD 0.20 (95% CI -4.08
to 4.48) respectively (Analysis 4.3).
Secondary outcomes
1. Self-management behaviour
a. Self-efficacy
At the six-month and 12-month follow-up, self-efficacy scores
were significantly greater in the ’Eat Well with CF’ than the stan-
dard treatment group, MD 4.20 (95% CI 1.51 to 6.89), and MD
3.30 (95% CI 0.56 to 6.04) respectively (Analysis 4.4).
3. Knowledge
At the six-month follow-up, disease-specific nutrition knowledge
scores were significantly greater in the ’Eat Well with CF’ group
than standard treatment group, MD 5.20 (95% CI 2.61 to 7.79).
The difference between groups was not statistically significant at
the 12-month follow-up, MD 2.90 (95% CI -0.22 to 6.02) (
Analysis 4.5) .
At the six-month and 12-month follow-up, there were no statisti-
cally significant differences between ’Eat Well with CF’ and stan-
dard treatment group in general nutrition knowledge scores, MD
0.70 (95% CI -1.20 to 2.60), and MD 0.90 (95% CI -09.93 to
2.73) respectively (Analysis 4.6).
4. Health-related quality of life
Data for analysis in the format required for the review could not
be extracted from published papers or unpublished data available
on this trial.
D I S C U S S I O N
Summary of main results
There have been few trials investigating the effects of self-man-
agement education for patients with CF and their caregivers. Four
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trials were included in our review involving 269 participants: chil-
drenwithCF and their parents or caregivers in three trials (Cottrell
1996; Downs 2006; Stapleton 2001); and adults with CF in one
trial (Watson 2008). The precise focus of self-management dif-
fered between trials and included a training programme for man-
aging CF (Cottrell 1996), education specific to aerosol and air-
way clearance treatments (Downs 2006), disease-specific nutri-
tion education (Stapleton 2001), and general and disease-specific
nutrition education (Watson 2008). The four trials differed in
the range of outcomes assessed, and in the number of assessment
time points. Primary outcomes relevant to our review were as-
sessed across two trials: pulmonary functioning (FEV1) (Watson
2008); weight (Cottrell 1996; Watson 2008); and dietary fat in-
take (Watson 2008). Secondary outcomes relevant to our review
were assessed in one or more of the four trials, and included self-
management behaviours, adherence, knowledge, and quality of
life. Utilisation of health services was not assessed in any of the
trials.
The evidence presented in this review is limited due the small
number of trials included, small sample sizes with inadequate or
unknown power calculations to detect effect size of outcomes mea-
sured, and unclear or high risk of bias in trials (see Characteristics
of included studies). The results reported in this reviewmust there-
fore be interpreted cautiously. The assessment of bias in trials is
important before interpreting the clinical significance of trial re-
sults by examining the confidence intervals around observed effect
sizes (Davies 2009). The included trials had a number of method-
ological limitations; therefore, the clinical significance of the trial
results is uncertain.
Results from one trial suggest that a self-management training
intervention can increase children’s knowledge about CF in the
short term (Cottrell 1996). However, the sample size of children
in the trial was very small (n = 20) and this is reflected in the wide
confidence intervals around the estimate of intervention effect re-
garding knowledge (see Effects of interventions). There were no
statistically significant differences between the self-management
training group and those receiving standard care for the remain-
ing outcomes assessed in the trial, which included parental knowl-
edge, self-management behaviours of children and parents, chil-
dren’s adherence to chest treatments, and children’s quality of life
(Cottrell 1996).
Unlike the self-management training programme (Cottrell 1996),
which focused on a broad range of CF areas such as digestive
problems, respiratory problems, and medications, the remaining
three trials each focused on a specific area of CF management.
Results from the trial on aerosol and airway clearance treatments
suggest that a 10-week self-management education intervention
using child-friendly information and behavioural exercises can in-
crease and sustain children’s knowledge about these treatments
over time (Downs 2006). The results also suggest that adherence
to chest treatments can increase following a self-management ed-
ucation intervention. The sample size of 43 children and their
caregivers in the trial was small, however, and this is reflected in
the wide confidence intervals around the estimates of intervention
effect regarding children’s knowledge and adherence (see Effects
of interventions). Evidence from this trial suggests that educa-
tion can result in immediate or short-term changes in some self-
management behaviours of caregivers in relation to aerosol and
airway clearance treatments, namely, assessment, communication
and treatment behaviours (Downs 2006).However, the differences
between groups were very small (see Effects of interventions), and
it is unclear if the differences in these behaviours are of any clinical
significance.
There is evidence to suggest that a 10-week programme on disease-
specific nutrition education can result in an immediate increase
in children’s nutrition and enzyme knowledge (Stapleton 2001).
However, the confidence interval around the estimate of interven-
tion effect on knowledge was wide (see Effects of interventions),
reflecting the small sample size of children in the trial (n = 41).
For caregivers, there were no statistically significant differences be-
tween groups in either knowledge or self-management behaviours
at the end of the intervention or at the 12-month follow-up. The
benefits of disease-specific nutrition education to children over
caregivers need to be considered within the context of learning
material used by children and caregivers together being in a format
appropriate for children of primary school age (Stapleton 2001).
This child-centred approach to education was also evident in the
trial regarding self-management of aerosol and airway clearance
treatments (Downs 2006). Therefore, the effects of self-manage-
ment education using written materials directed at caregivers in
relation to nutrition or chest treatments remains unknown from
our review.
Only one trial sampled adults with CF (Watson 2008). Results
from this trial suggest that a home-based behavioural nutrition ed-
ucation programme can result in a short-term increase in disease-
specific nutrition knowledge, and enhanced self-efficacy (confi-
dence) in ’coping’ with nutritional requirements for CF in the
short and long term. However, the sample size in the trial was very
small (n = 48), and this is reflected in the wide confidence in-
tervals around the estimate of intervention effects on disease-spe-
cific nutrition knowledge, and self-efficacy respectively (see Effects
of interventions). Differences between groups in general nutri-
tion knowledge were not statistically significant. There were no
statistically significant differences between groups in pulmonary
function (FEV1), changes in weight, or dietary fat intake. In the
Watson trial 74 adults with CF were recruited; however, the trial
was discontinued with a final sample of 48 patients because of
microbiological segregation policies that prohibited group educa-
tion (Watson 2008). This situation illustrates a challenge that can
arise when including group workshops as part of an education
programme for patients with CF because of concerns about cross-
infection. The trial authors have since piloted an interactive web-
based meeting to replace group workshops in a nutrition educa-
tion programme but data about its effects are not available as yet.
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Overall completeness and applicability of result
Only four trials eligible for inclusion in this review were identified.
Because of the small number of trials and respective small sample
sizes, results cannot be generalised to subgroup populations of
patients with CF (children or adolescents or adults) or to their
parents or caregivers. We planned to do subgroup analysis to
make comparisons between subsets of participants according to
age groups. However, subgroup analysis was not possible because
of the small number of similar age groups across trials. In two
trials, children were aged 6 to 11 years (Downs 2006; Stapleton
2001). Adolescents were included in one trial (Cottrell 1996) and
adults were included in one trial (Watson 2008).
From the current available evidence, it is not known what com-
ponents of self-management education interventions would work
best for various subgroups of individuals with CF in terms of im-
proving health outcomes. While knowledge is typically included
as a component of health education programmes, knowledge gains
are unlikely to translate into changes in behaviour. Self-manage-
ment education needs to include behavioural components that are
problem-based focusing on skills of goal setting, action planning,
and self-monitoring (Lorig 2003; Schreurs 2003). There was lit-
tle consistency across the trials regarding behavioural skills taught
and none of the trials included the range of skills recommended
for self-management education (Lorig 2003; Schreurs 2003). Goal
setting was included in two trials (Stapleton 2001; Watson 2008)
and self-monitoring was included in one trial (Stapleton 2001).
None of the four trials described action planning as part of the
intervention content.
Behavioural changes for integrating the complex demands of CF
management into a person’s daily life are likely to need ongoing
reinforcement. The interventions across the four trials were short
in duration (6 to 10 weeks) and did not include top-up or booster
sessions. Therefore, the potential benefits of ongoing reinforce-
ment to changing behaviours for self-management of CF remain
unknown.
The mode of delivery in the four trials reviewed was standard-
ised, themost common being home-based pen and paper exercises
(Downs 2006 Stapleton 2001; Watson 2008). Standardised pro-
grammes are likely to have maximum effectiveness in a proportion
of those to whom they are delivered because learning styles and
preferences for mode of delivery can vary among individuals and
families.
Evidence on the effects of self-management education on out-
comes relevant to this review is incomplete. The four trials dif-
fered in the range of outcomes assessed, and the number of post-
intervention assessment time points. Data on primary outcomes
were presented across two trials only, and included indices of nu-
tritional growth (weight, dietary fat intake), and pulmonary func-
tioning (FEV1). Data on three secondary outcomes were available
for analysis in one or more of the trials. However, the precise focus
of assessment for similar outcomes differed between trials includ-
ing the type of self-management behaviours assessed, aspects of CF
treatments assessed for adherence, and the type of CF knowledge
assessed. Quality of life of patients with CF was assessed in two
trials but data were available for analysis from one trial only. No
data on utilisation of health services were presented in any of the
trials.
Quality of the evidence
The evidence on which this review is based draws on data from
four trials involving 269 participants, and which included children
with CF and their parents or caregivers, and adults with CF. Based
on our assessment of the risk of bias in the included trials, the
quality of the evidence presented in this review is limited. There
were concerns over the integrity of the randomisation process in
all trials: generation of allocation sequence was unclear in one trial
(Cottrell 1996); method of allocation concealment was judged to
be low risk in one trial only (Watson 2008). Insufficient detail
about blinding was provided in the four included trials. Only one
trial was judged to be low risk for the criterion on incomplete
outcome data (Watson 2008). Insufficient detail about missing
data were provided in three of the trials (Cottrell 1996; Downs
2006; Stapleton 2001). There were concerns over the quality of
reporting in all four trials: it was unclear if additional outcomes
were pre-specified in the trial protocols but not reported. Apart
from one trial (Cottrell 1996), there were no concerns about the
remaining three trials in terms of being ’free of other bias’. In
conclusion, the available evidence from this review is of insufficient
quantity and quality to draw any firm conclusions about the effects
of self-management education for CF.
Potential biases of the review process
Our objective was to include trials on educational interventions
that explicitly addressed self-management for CF in the aims of
the programme or content of the programme. We are confident
that through our search strategy, we have identified all trials con-
ducted on self-management education for CF within the years
covered in this review (1990 to February 2011). The selection of
trials, risk of bias assessment, and data extraction were conducted
by two authors. Disagreements were resolved by discussion. We
were successful in obtaining additional information from the au-
thors of three trials (Downs 2006; Stapleton 2001; Watson 2008).
Our inclusion of only those trials that explicitly referred to self-
management in the aims or content of interventions has resulted
in the exclusion of one trial that evaluated the effectiveness of
a CD-ROM educational programme (STARBRIGHT) aimed at
helping children and adolescents fit the demands of CF care into
their everyday lives (Davis 2004). This educational programme
included coping skills training to deal with stressors and problems
that children and adolescents may encounter in their daily lives
because of CF. In future updates of this review, it is planned to
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include education programmes that have behavioural components
such as coping, provided that the programme is designed to help
patients and their caregivers integrate CF management into their
daily lives.
Agreement or disagreements with other studies
or review
The evidence from the four trials included in our review are broadly
in agreement with some results from other Cochrane reviews on
self-management education programmes across a range of spe-
cific chronic illnesses including: epilepsy in children (Stokes 2007)
and adults (Bradley 2008; Shaw 2007); asthma in adults (Gibson
2002); type-2 diabetes in adults (Deakin 2005); and chronic ob-
structive airway disease (COPD) in adults (Effing 2007). Previ-
ous Cochrane reviews relating to respiratory conditions suggest
that self-management education has no statistically significant ef-
fect on pulmonary function in adults (Effing 2007; Gibson 2002)
which is in agreement with our review. Similar to our review, evi-
dence fromCochrane reviews relating to epilepsy suggests that self-
management education may improve disease-related knowledge
in children (Stokes 2007) and adult patients (Bradley 2008; Shaw
2007). Likewise, there is some previous evidence to suggest that
self-management education may improve certain behavioural out-
comes (Bradley 2008 Deakin 2005; Shaw 2007). Results from two
previous Cochrane reviews indicate that self-management educa-
tion has a statistically significant effect on quality of life in adults
with COPD (Effing 2007) and asthma (Gibson 2002). There is no
evidence available from our review regarding quality of life in adult
patients with CF, since data for analysis in the format required
for the review could not be extracted from published papers or
unpublished data available on the trial (Watson 2008). Similar to
other Cochrane reviews, we included ’utilisation of health services’
as a secondary outcome of interest. However, this outcome was
not assessed in any of the four trials in our review. This contrasts
with previous Cochrane reviews that have presented evidence in-
dicating that self-management education has a statistically signifi-
cant effect on reducing hospital admissions in adult patients with
COPD (Effing 2007) and asthma (Gibson 2002); and in reducing
emergency room visits in children with epilepsy (Stokes 2007).
Apart from two Cochrane reviews on self-management education
for epilepsy (Shaw 2007; Stokes 2007), the evidence presented
in other Cochrane reviews has been drawn from a greater num-
ber of trials than included in our review (Bradley 2008; Deakin
2005; Effing 2007; Gibson 2002). However, similar to our review,
there were concerns about the risk of bias in trials. Apart from one
Cochrane review (Deakin 2005),meta-analysis was not conducted
in other Cochrane reviews on specific chronic illnesses (Bradley
2008; Effing 2007; Gibson 2002; Shaw 2007; Stokes 2007), due
to heterogeneity in study samples, interventions, outcome mea-
sures and assessment time points. Likewise, in our review, the het-
erogeneity of trials precludedmeta-analysis. To date, there remains
uncertainty about the effects of self-management education on a
range of health outcomes due to insufficient evidence, and previ-
ous Cochrane reviewers have consistently recommended the need
for more RCTs with longer follow-up, before firm conclusions can
be made. Our review concurs with these conclusions and recom-
mendations regarding further research.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Due to the limited quantity and quality of trials included in this
review, as well as the clinical and methodological heterogeneity
of these trials, there is insufficient evidence to clearly recommend
or refute the use of self-management education for CF in routine
clinical practice. There is some limited evidence to suggest that
self-management education may improve knowledge in patients
with CF but not in parents or caregivers. There is also some lim-
ited evidence that self-management education may result in pos-
itively change a small number of behaviours in both patients and
caregivers. However, improvements in knowledge and behaviours
were mostly short lived and were not maintained over time. To
sustain the potential benefits of self-management education, top-
up or booster sessions may be needed.
Implications for research
Well-designed RCTs are needed to evaluate the effects of self-man-
agement education for CF. The behavioural component of self-
management education programmes needs to be strengthened to
include the skills of goal setting, action planning, and self-moni-
toring aimed at helping patients and families to fit treatment re-
quirements into their everyday activities around flexible manage-
ment plans. Behavioural change is a gradual process and future
self-management programmes need to be developed from a be-
havioural framework that takes account of a person’s position in
the change process such as the ’Transtheoretical Model of Change’
(also known as ’Stages of Change’ model).
Further trials are needed to evaluate the effects of self-manage-
ment education in relation to: intervention types (e.g. web-based
learning, computer-aided programmes, written materials); con-
tent of intervention (e.g. learning material about CF; skills train-
ing; behavioural training); format of interventions (e.g. individual,
group, patient-caregiver pairs); duration of interventions includ-
ing top-up or booster sessions, intervention settings (e.g. home,
hospital, school); and personnel delivering interventions (e.g. di-
etitians, nurses, physicians, physiotherapists, CF advocacy or vol-
untary groups). Consideration also needs to be given to the effects
of tailoring interventions to the personal preferences of partici-
pants. The potential for control group contamination in educa-
tional interventions needs to be addressed by designing trials that
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seek to avoid contamination or if this is unavoidable, the perfor-
mance of power calculations to determine sample size needs to
take account of this.
There is a need for consistency in the type of outcomes measured
and follow-up time points. Of particular importance is the need
to investigate the long-term effects of self-management education
on pulmonary function and nutritional growth and health since
these outcomes are critical indicators of physical health and long-
term survival in people with CF.
A wide range of age groups and in sufficient numbers need to be
enrolled into trials so that data on subgroups can be analysed sep-
arately. Therefore, future trials need to be adequately powered to
detect small differences between intervention and control groups.
An important consideration here is whether small differences are
of any clinical importance to patients. Therefore, researchers con-
ducting future trials need to define theminimum clinically impor-
tant difference that is worth detecting between intervention and
control groups for the primary outcome of interest.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cottrell 1996
Methods RCT, parallel design.
Participants 34 families were enrolled in the study.
20 children (aged 8 to 18 years, mean 13.5) and their parents (18 families) completed
the study through to follow-up assessment (10 children and 10 parents in intervention
group, 10 children and 10 parents in control group)
Gender: intervention group (6 males, 4 females); control group (4 males, 6 females)
Mean (SD) disease severity as rated independently by 3 CF centre physicians on a 10-
point scale from very severe (1) to no involvement (10): intervention group - pulmonary
system = 7.03 (1.614), digestive system = 6.21 (1.438); control group - pulmonary
system = 7.08 (2.162); digestive system = 6.94 (1.37). Differences between groups were
not statistically significant
The study was conducted with families from the CF centre of a children’s hospital in
Columbus, Ohio, USA
Interventions Self-management training for CF.
Content: knowledge on the nature of CF (anatomy, physiology, pathophysiology, phar-
macology) and principles of self-management (prevention, early warning signs of illness
exacerbations, self-management strategies for problems with salt loss, maldigestion, res-
piratory problems, medications and principles of communication); skills on problem
solving and stress management techniques
Mode of delivery: group sessions (2 x 6 hours). Children and parents were grouped
together for delivery of knowledge component. Separate groups for children and parents
to tailormaterial respectively. Group sessions delivered by registered nurse or psychologist
Duration: time frame between 6-hour sessions not stated.
Setting: CF centre, Children’s Hospital, Columbus, Ohio, USA
Outcomes Children: weight (lb); quality of well-being; self-management behaviours; compliance
to prescribed medications, aerosol treatment, and chest physiotherapy; knowledge of CF
and its management
Parents: self-management behaviours; knowledge of CF and its management
Assessment time points: baseline and 6-8 weeks post intervention
Notes The performance of power analysis and sample-size estimation was not reported. The
trials authors stated that: “The limited number of subjects in the present study reduced
the power of statistical procedures” (Cottrell 1996: page 116).
Mothers of all children in intervention and control groups (n = 18) participated, and 2
fathers participated, 1 in each group
For the 20 children who completed the study, the trial authors reported that groups were
equivalent at baseline on years since diagnosis and disease severity
Although weight was reported in pounds (Ib), this review has reported equivalent calcu-
lations in kilograms (kg)
Risk of bias
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Cottrell 1996 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were “randomly assigned to a self-management or
control group” (Cottrell 1996: page 110). No further details are
provided by the trial authors
Allocation concealment (selection bias) Unclear risk No details are provided by the trial authors.
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No details are provided by the trial authors. However, the nature
of the intervention prohibits blinding of trial participants. It is
unclear if the CF centre physicians who “completed the post
treatment record form on each participant” (Cottrell 1996: page
113) were blinded. It is unclear if the providers of care, outcome
assessors of self-management behaviours and quality of well-
being (involving interviews with participants) and data analysts
were different to the personnel delivering the programme, and
if so, whether they were blinded from knowing which group
participants were randomised to
Incomplete outcome data (attrition bias)
All outcome
Unclear risk Of the 34 participants enrolled, “2 families withdrew due to ill-
ness of a family member, 2 withdrew because of family vacations
and 10 did not return diaries” (Cottrell 1996: page 110). It is
unclear if the 4 participants who withdrew had been randomised
following enrolment. It is unclear which groups the 10 non-
respondent families were allocated to. The trial authors provide
no details on why 10 families dropped out
Selective reporting (reporting bias) Unclear risk All outcomes mentioned in the published and unpublished
records are reported. It is unclear if additional outcomes were
pre-specified in the study protocol but not reported
Other bias High risk Themean (SD) baseline weightmeasurement for children in the
intervention group was 89.5 (29.29) lb and for children in the
control group was 101.4 (32.17) lb. This difference indicates a
clinically important baseline imbalance in the case of CF
Downs 2006
Methods Multicentre RCT, parallel design.
Participants 62 children (aged 6 to 11 years) and their caregivers were recruited and randomised to
either an intervention (n = 33) or control (n = 29) group
43 child/caregiver pairs completed the study through to 12-month follow-up assessment
(18 in intervention group; 25 in control group)
Gender: intervention group (8 males, 10 females); Control group (16 males, 9 females)
Mean age (SD): intervention group 8.4 (1.8) years; control group 8.4 (1.5) years
For inclusion, children had to be fluent in English, have no learning difficulties, be
currently performing ACT as part of a home management programme but not taking
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Downs 2006 (Continued)
part in other CF self-management programmes
The study was conducted with children and caregivers from the CF centres of 3 public
children’s hospitals in Australia (Western Australia, South Australia and New South
Wales)
Interventions Self-management education on aerosol and airway clearance treatments (’Airways’)
Content: knowledge integrated from disciplines of medicine physiotherapy, psychology
and education; self-management skills on practical assessment, treatment implementa-
tion and decision making, strategies to overcome barriers to treatment
Mode of delivery: pen andpaper programme consisted of 10 ’chapters’ completed by child
and caregiver dyads; each chapter provided child friendly information and behavioural
exercises, and took approximately 20 minutes to complete
Duration: 10 weeks.
Setting: home.
Outcomes Children: adherence to aerosol treatment and to airway clearance treatment; knowledge
about airway clearance treatment
Caregivers: self-management behaviours; responsiveness of airway clearance treatment;
performance when child unwell; self-efficacy to manage chest treatments
Assessment time points: baseline; post-intervention; 6- and 12-month follow-up (chil-
dren’s knowledge was not assessed at 6-month follow-up)
Notes Power calculations from available self-efficacy data were performed. The trial authors
stated that: “A 15% improvement (0.6 points) in self-efficacy on a Likert scale was
considered to be clinically significant and 64 caregiver child dyads were required giving
a power at an alpha level of 0.05” (Downs 2006: page 21)
The trial authors reported that children in intervention and control groups were equiv-
alent on gender, age and FEV1.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The trial authors report that “Following recruit-
ment at each participating centre, participants were
stratified according to the child’s age (six to eight
andnine to eleven years) and allocated to the control
of intervention group using randomised permuted
blocks” (Downs 2006: page 21). Information pro-
vided by the principal author on request states that
“children and their caregiver were seen sequentially
and the allocation from a random numbers table
was also sequential”
Allocation concealment (selection bias) High risk No details are provided by the trial authors in
the published record. Information provided by the
principal author on request states that allocation
was not concealed
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Downs 2006 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No details are provided by the trial authors in
the published record. Information provided by the
principal author on request states that “The chil-
dren and primary caregivers (the subjects) com-
pleted questionnaires for the outcomes reported in
the paper and they could not have been blind to
the treatment (an education program) they had re-
ceived”. Outcome on pulmonary function and in-
dices of growth were “measured by blinded asses-
sors”. It is unclear if providers of care or data ana-
lysts were blinded from knowing which group par-
ticipants were randomised to
Incomplete outcome data (attrition bias)
All outcome
Unclear risk The published diagram showing the flow of par-
ticipants at each stage of the study states that “65
families recruited to the study and randomised to
the intervention or control group” (Downs 2006:
page 22). The number allocated to each group is re-
ported as: 33 to intervention and 29 to control. The
reason for the disparity in participant numbers (62
in intervention and control groups vs 65 allocated
to groups) was not published but was sought from
the principal author who advised that 3 participants
recruited to the study withdrew prior to allocation.
Of the 33 allocated to the intervention group: 7 did
not complete baseline assessment; and 8 withdrew
prior to or subsequent to commencing the pro-
gramme.Of the 29 allocated to the control group: 4
did not complete baseline assessment. The trial au-
thors state that “Attrition after recruitment related
to failure to complete the pre- or post-intervention
questionnaires, withdrawal from the intervention
or miscellaneous factors” (Downs 2006: page 22)
. It is unclear why participants failed to complete
questionnaire or withdrew. Intention-to-treat anal-
ysis was conducted by combining data from partic-
ipants in the per-protocol analysis with the 8 par-
ticipants in the intervention group who withdrew
from the study. Outcome data analysed (relevant
to this review) were adherence, children’s knowl-
edge of airway clearance treatment, and caregivers
responsiveness of airway clearance treatment when
child was unwell. The trial authors state that “Pre-
intervention scores were imputed into the missing
post-intervention and follow-up assessment data”
(Downs 2006: page 23).
27Self-management education for cystic fibrosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Downs 2006 (Continued)
Selective reporting (reporting bias) Unclear risk All outcomes reported in the published record are
stated by the trial authors as being ’per-protocol
analysis’. It is unclear if additional outcomes were
pre-specified in the study protocol but not reported
Other bias Low risk No other potential source of bias identified.
Stapleton 2001
Methods RCT, parallel design.
Participants 59 children aged 2 to 11 years and their caregivers were enrolled and randomised in
the study. Of these, children aged 6 to 11 years only were randomly allocated to an
intervention (n = 22) or control (n = 21) group. Caregivers of the participating children
aged 6 to 11 years and of younger children aged 2 to 5 years were randomly allocated
to the intervention (n = 28) or control (n = 28) group. 3 caregivers each had 2 children
with CF
41 children aged 6 to 11 years (21 in intervention group, 20 in control group) and 54
caregivers of children aged 2 to 11 years (27 in intervention group, 27 in control group)
completed the study through to 12 month follow-up assessment
Gender: intervention group (11 males, 10 females); control group (11 males, 10 females)
For inclusion, children had to be aged between 2 and 11 years at baseline data collection
and have pancreatic insufficiency. Children were excluded if they had pancreatic suffi-
ciency, short gut syndrome, liver disease requiring drug therapy, on enteral tube feeding,
or had marked language delay
The study was conducted with children and caregivers from the CF clinics of 2 children’s
hospitals in Perth, Western Australia
Interventions Disease-specific nutrition education (’Go and Grow with CF’)
Content: knowledge on disease-specific nutrition topics (enzymes, energy and fat, mal-
absorption, vitamins and minerals, growth, snacks, and salt); self-management skills on
goal setting in small incremental steps to increase self efficacy; and self-monitoring ad-
herence to daily goals
Mode of delivery: written material focusing on weekly activities completed by child and
caregiver dyads, taking approximately 60 minutes each week. Supplementary introduc-
tory and concluding workshops, and monthly telephone calls delivered by a dietitian
Duration: 10 weeks.
Setting: home (weekly written activities) and hospital (workshops)
Outcomes Children: knowledge of nutrition and enzymes; self-management skills to deal with
malabsorption
Parents: knowledge of malabsorption and vitamins; self-management to deal with mal-
absorption
Assessment time points: baseline, post-intervention, and 12-month follow-up
Notes Sample-size calculations were performed based on changes in percentage of ideal body
weight. The trial authors stated that: “It was determined that 20 subjects per group
would be sufficient to detect a mean difference in percentage of ideal body weight of 2.
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Stapleton 2001 (Continued)
5%, with a statistical power of 85% and Type I error = 0.05. In order to account for the
possibility of drop-outs the number of subjects recruited was based on the maximum
number of children eligible for the clinical trial” (Stapleton 2001: page 166).
Weight was not measured as an outcome of this trial.
The trial authors state that children aged 2 to 11 years were randomly assigned to an
intervention or control group. However, caregivers only of children younger than 6 years
were randomised and these children were not directly involved in the trial
Information on gender of children allocated to groups is unpublished and was provided
by principal author on request
Information provided by the principal author on request states that participants had
“similar characteristics prior to the intervention in terms of age, pulmonary function,
height and weight, gender, genotype, PERT, socio-economic status, illness and activity”.
Study was funded in part by The Merck, Sharp and Dohme Research Foundation,
Jannsen-Cilag Pty Ltd., Roche products Ltd., Solvay Pharmaceuticals, the Princess Mar-
garet Hospital for Children Allied Health Trust Fund, and Curtin University of Tech-
nology
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The trial authors state that “children and their carers were ran-
domly assigned (using a random number table) to participate in
the intervention group” (Stapleton 2001: page 165). Informa-
tion provided by the principal author on request states that “ran-
dom allocation sequence (random number table) was applied..
.with 30 being randomly assigned to the intervention program
and 29 randomly assigned to the control group”
Allocation concealment (selection bias) Unclear risk No details are provided by the trial authors in the published
records. Informationprovided by the principal author on request
states that “Allocation sequence of participants was unknown
by personnel collecting data”. No further details are provided by
the trial authors
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No details are provided by the trial authors in the published
records.However, the nature of the intervention prohibits blind-
ing of trial participants. Information provided by the principal
author on request states that “Personnel collecting the data were
not informed of group allocation and were not involved in the
intervention program and were advised to immediately direct
any and all enquiries and comments to the investigators without
engaging in any related discussion. The success of blinding was
not evaluated, but the investigators were in frequent and close
contact with personnel to reaffirm the importance of blinding”.
It is unclear if providers of care or data analysts were blinded
from knowing which group participants were randomised to
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Incomplete outcome data (attrition bias)
All outcome
Unclear risk The trial authors state that following enrolment and random
allocation into intervention or control groups, the “carer of one
child chose for their family not to participate in the ’Go and
Grow with CF’ intervention program due to time constraints,
and their data were excluded from the analysis” (Stapleton 2001:
page 165). It is unclear what data were collected and subse-
quently excluded from analysis. 1 child and caregiver from the
control group relocated following post-intervention assessment
and were unavailable for follow-up assessment at 12 months
Selective reporting (reporting bias) High risk The trial authors state that the “differences between groups for
the children’s and carers’ self-management scores were not sta-
tistically significant” (Stapleton 2001: page 166). No further de-
tail on these scores are provided by the authors in the published
records of the study.The trial authors selectively reported ondata
specific to communication aspects of self-management stating
that at “time 2, a greater number of children in the intervention
group compared to the control group reported communicating
with their carers when they experienced signs of possible mal-
absorption (intervention group: Time 1, 9 and Time 2, 12 out
of 21; control group: Time 1, 14 and Time 2, 10 out of 21)”
(Stapleton 2001: page 166). It is unclear if additional outcomes
were pre-specified in the study protocol but not reported
(Note:Data on self-management skills scores for each assessment
point were provided by the principal author on request.)
Other bias Low risk No other potential source of bias identified.
Watson 2008
Methods RCT, parallel design.
Participants 74 adults were enrolled and stratified by disease severity into low or high risk disease.
Equal numbers of adults were randomly allocated into intervention (n = 37) and control
(n = 37) group
48 adults completed the study through to 12-month follow-up assessment (23 in inter-
vention group, 25 in control group)
Gender: intervention group (12 males, 11 females); control group (14 males, 11 females)
Mean (range) age: intervention group 26.4 (17.2 - 43.2) years; control group 24.2 (16.
9 - 38.1) years
Disease status: intervention group - mean BMI (kg/m2) = 21.3; pancreatic insufficiency
(n = 21); Psuedomonas aeruginosa in sputum (n = 18); non-Psuedomonas (n = 5); ho-
mozyous DF508 (n = 13); heterozygous DF508 (n = 7); other (n = 3); control group -
mean BMI (kg/m2) = 21.1; pancreatic insufficiency (n = 22); Psuedomonas aeruginosa in
sputum (n = 21); non-Psuedomonas (n = 4); homozyous DF508 (n = 16); heterozygous
DF508 (n = 8); Other (n = 1)
For inclusion, participants had to be older than 16 years, able to understand written
English, not partaking in other research. Participants were excluded if theywere on heart/
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Watson 2008 (Continued)
lung transplant list or were pregnant or lactating
The study was conducted with adults from the CF clinic of Papworth Hospital, Cam-
bridge, UK. The duration of the study was from January 2003 to August 2005
Interventions General and disease-specific nutrition education (’Eat Well with CF’)
Content: knowledge on general and disease-specific nutrition topics (energy intake, di-
gestion, pancreatic enzyme replacement, managing appetite, exercise, dietary fibre, read-
ing food labels, body image); self-management skills on goal setting in small incremental
steps to establish new behaviours
Mode of delivery: written material focusing on weekly activities, taking approximately
30 minutes each week; supplementary workshops (introductory, weeks 5 and 10) and
weekly telephone calls delivered by a dietitian
Duration: 10 weeks.
Setting: home (weekly written activities) and hospital (workshops)
Outcomes Weight (kg); pulmonary function (FEV1); self-efficacy; knowledge of nutrition (general
& disease-specific); dietary fat intake; health-related quality of life
Assessment time points: baseline; 6- and 12-month follow-up.
Notes The primary outcome measure of an increase in weight after 12 months was used to
calculate the required sample size. For this, data on weight gain in patients attending
the CF clinic of the study centre from 1998 to 2000 were reviewed. The trial authors
stated that: “By using the ’Eat Well with CF’ programme it was anticipated that subjects
mean (SD) weight would increase by 3 (3) kg after 12 months. With 80% power and
two-sided significance of 5% and allowing for 15% dropout or loss to follow-up, the
recruitment target was 46 participants per group” (Watson 2008: page 848).
The trial authors define high disease risk as participants with < 30% predicted FEV1, on
enteral feeding, or with diabetes.
Microbiological segregation was introduced during the course of the study which pro-
hibited the use of group workshops. Consequently the study could not continue and
therefore target levels of recruitment could not be achieved
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The trial authors state that a “minimisation method of randomi-
sation was used to ensure that the same number of patients were
allocated to each group” (Watson 2008: page 848).
Allocation concealment (selection bias) Low risk No details are provided by the trial authors in the published
records. Informationprovided by the principal author on request
states that “an independent randomiser was used who was part
of the R and D [Research and Development] department of the
hospital”. and which was “supervised by the project statistician.
..independently of the investigator”
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Blinding (performance bias and detection
bias)
All outcomes
Unclear risk The trial authors state that “The study could not be blinded to
either the subjects or the investigators because of the nature of the
intervention” (Watson 2008: 848). Information provided by the
principal author on request states that “no blinding” of outcome
assessors took place. It is unclear if providers of care or data
analysts were blinded from knowing which group participants
were randomised to
Incomplete outcome data (attrition bias)
All outcome
Low risk Of the 74 adults enrolledwith equal numbers in the intervention
(n = 37) and control (n = 37) groups, 48 were included in the
“completer analysis” at 12months follow-up (23 in intervention
group, and 25 in control group). Incomplete outcome data are
reported for each assessment point for intervention and control
groups as follows:
Intervention group: baseline data are reported as missing from
3 of the 37 allocated to group due to relocation (n = 1) and
non-return of questionnaires (n = 2). At 6 months follow-up,
data from a further 6 participants are reported as missing due to
withdrawal from the study (n = 3), defaulting from follow-up (n
=2) or death (n=1). At 12months follow-up, data froma further
5 participants are reported as missing due to defaulting from
follow-up (n = 4) or death (n = 1). The number of participants
in the intervention group included in the “completer analysis”
is reported as 23
Control group: baseline data are reported as missing from 3 of
the 37 allocated to group due to relocation (n = 1) and non-
return of questionnaires (n = 2). At 6 months follow-up, data
from a further 2 participants are reported as missing due to
relocation (n = 1) or death (n = 1). At 12 months follow-up,
data from a further 7 participants are reported as missing due to
defaulting from follow-up (n = 6) or death (n = 1). The number
of participants in the control group included in the “completer
analysis” is reported as 23
Missing outcome data are balanced in numbers across both
groups with similar reasons for missing data across both groups
Selective reporting (reporting bias) Unclear risk All outcomes mentioned in the published record are reported. It
is unclear if additional outcomes were pre-specified in the study
protocol but not reported
Other bias Low risk No other potential source of bias identified.
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ACT: airway clearance techniques
CF: cystic fibrosis
FEV1: forced expiratory volume at 1 second
PERT: pancreatic enzyme replacement therapy
RCT: randomised controlled trial
SD: standard deviation
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bartholomew 1997 Not a RCT or quasi-RCT or CCT.
Bartholomew 2000 Not a RCT or a quasi-RCT or a CCT.
Bosworth 1997 No explicit focus on self-management education in the aims or content of the programme. Home versus
hospital treatment of intravenous antibiotics and chest physiotherapy
Byron 2000 No explicit focus on self-management education in the aims or content of the program. Home-visit program
Chernoff 2002 No explicit focus on self-management education in the aims or content of the program. Community based
support programme
Christian 2006 No explicit focus on self-management education in the aims or content of the program. Life skill program
focusing on psychological adjustment, functional and physiological health
Cox 1994 Not a RCT or quasi-RCT or CCT.
David 2008 Not a RCT or quasi-RCT or CCT.
Davis 2004 No explicit focus on self-management education in the aims or content of the program. Educational program
focusing on knowledge about cystic fibrosis and coping strategies
de Jong 1994 No explicit focus on self-management education in the aims or content of the program. Home exercise training
program
Goldbeck 2001 Not a RCT or quasi-RCT or CCT.
Hains 2001 Not a RCT or quasi-RCT or CCT.
Hourigan 2013 No explicit focus on self-management education in the aims or content of the program. Behavioural parent-
training intervention for improving nutrition
Klijn 2004 No explicit focus on self-management education in the aims or content of the program. Anaerobic training
program
Moorcroft 2004 No explicit focus on self-management education in the aims or content of the program. Unsupervised home
based exercise program
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Orenstein 2002 No explicit focus on self-management education in the aims or content of the program. Exercise training
program
Power 2006 No explicit focus on self-management education in the aims or content of the program. Behavioural and
nutrition treatment program
Quittner 2000 No explicit focus on self-management education in the aims or content of the program. Focus on treatment
adherence using family learning program or behavioural family system therapy
Quittner 2011 No explicit focus on self-management education in the aims or content of the program. Behavioural adherence
program with a primary focus on medication adherence titled I change adherence and raise expectations
(iCARE)
Quittner 2012 No explicit focus on self-management education in the aims or content of the program. Cell phone (CFfone)
social networking intervention to promote treatment adherence in adolescents
Singer 1991 Not a RCT or quasi-RCT or CCT.
Stark 1996 Not a RCT or quasi-RCT or CCT.
Stark 2009 No explicit focus on self-management education in the aims or content of the program. Behavioural plus
nutrition intervention program
Trapp 1998 No explicit focus on self-management education in the aims or content of the program. Hospital self-admin-
istration of medication program
Turchetta 2004 Not a RCT or quasi-RCT or CCT.
Tuzin 1998 Not a RCT of quasi-RCT or CCT.
CCT: controlled clinical trial
RCT: randomised controlled trial
Characteristics of studies awaiting assessment [ordered by study ID]
Bergman 2007
Methods RCT, parallel design.
Participants 67 patients with CF aged 21 years or less.
Interventions Web-based interactive chronic illness program titled CF:DOC which was designed in part to promote self-manage-
ment skills. Half the group were randomised into either an intervention or control group. Control group received
’usual care’
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Bergman 2007 (Continued)
Outcomes Change in weight for age; change in height for age; self-care behaviours
Notes Study was published in the Cystic Fibrosis Worldwide Newsletter in 2007 For updated review, the principal author
was contacted again for information. A response is awaited
Cannon 1999
Methods Not explicit.
Participants 10 children aged 6-13 years.
Interventions Educational messages delivered through in-home video-conferencing plus routine clinic education. Control group
received routine clinic education
Outcomes Pulmonary function tests; indices of nutritional status and growth (weight, triceps skin fold thickness, mid-arm
muscle circumference); knowledge
Notes Study published in an abstract. Efforts to locate contact details on any one of the authors have failed
Jessup 2008
Methods RCT, 3-arm design.
Participants 19 adolescents and adults.
Interventions Mentorship plus IT-based self-monitoring on CF patients’ self-efficacy and self-management behaviours of 6 months
duration followed by a ’washout period’
Participants were allocated to an intervention group or mentorship only group or control group
Outcomes No detail provided other than ’behavioural changes’.
Notes Study published in 3 abstracts. Principal author contacted for information. A response is awaited
Johnson 2001
Methods RCT, delayed treatment design.
Participants Children with CF and type 1 diabetes.
Interventions Clinic-based Adherence Intervention for Diabetes & CF (staged self-management intervention)
Outcomes
Notes Information provided by principal author. Study has been conducted in Australia with a sample of children with type
1 diabetes. It is planned to conduct this study in the USA with a sample of children with CF
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Van der Gieesen 2006
Methods RCT, parallel design.
Participants 37 children with cystic fibrosis aged 7-13 years; 11 were allocated to an intervention group and 20 were allocated to
control group
Interventions Board game ’Airway’ to increase knowledge about CF lung disease including treatment
Outcomes Knowledge.
Notes Study published in an abstract. For updated review, principal author contacted again who replied indicating that
there was still no published information about the study available
Wainwright 2009
Methods RCT, parallel design.
Participants 46 adolescents and young adults with CF aged 12 to 19 years. Participants were allocated into 3 groups: standard care
group (controls, n = 15); standard care plus phone mentoring group (n = 16); or standard care plus phone mentoring
plus IT tool group (n = 15)
Interventions Phone mentoring compared to phone mentoring plus IT Tool to facilitate electronic self-reporting of symptoms.
Mentoring focused on facilitating self-management
Outcomes Self efficacy; quality of life; pulmonary function by spirometry; weight z scores; height z scores
Notes Study was published in abstract form. Principal author contacted for further information. A response is awaited
CF: cystic fibrosis
RCT: randomised controlled trial.
Characteristics of ongoing studies [ordered by study ID]
Huang 2009
Trial name or title Texting to promote chronic disease management.
Methods RCT.
Participants Individuals with CF aged 14 to 22 years. Individuals with type 1 diabetes, or inflammatory bowel disease for
at least 6 months also included
Interventions Web- and text-based self-management information, tips, strategies and questions versus usual care
Outcomes Health knowledge, disease health knowledge, health literacy, quality of life
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Huang 2009 (Continued)
Starting date 2009.
Contact information Huang Jeannie, University of California, San Diego, USA.
Notes No published data identified in updated search strategy.
CF: cystic fibrosis
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. Self-management training versus standard treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in weight (Children) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of digestive system
self-management behaviours
(Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of pulmonary system
self-management behaviours
(Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Frequency of digestive system
self-management behaviours
(Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Frequency of pulmonary system
self-management behaviours
(Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Total frequency of digestive and
pulmonary self-management
behaviours (Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Adherence - percentage of
prescribed medications taken
by children
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Adherence - percentage of
prescribed aerosol treatment
taken by children
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
8.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Adherence - percentage of
prescribed chest physiotherapy
treatment taken by children
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Knowledge of cystic fibrosis
and its management (Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Quality of well-being
(Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
11.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Number of digestive system
self-management behaviours
(Parents)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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12.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Number of pulmonary system
self-management behaviours
(Parents)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
13.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Total number of digestive and
pulmonary self-management
behaviours (Parents)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
14.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Frequency of digestive system
self-management behaviours
(Parents)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
15.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Frequency of pulmonary system
self-management behaviours
(Parents)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
16.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Total frequency of digestive
and pulmonary system
self-management behaviours
(Parents)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
17.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Knowledge of cystic fibrosis
and its management (Parents)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
18.1 6 to 8 weeks follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 2. Self-management education on aerosol and airway clearance treatments (’Airways’) versus standard
treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Adherence - percentage of
prescribed aerosol treatment
taken by children
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Adherence - percentage of airway
clearance treatments taken by
children
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Knowledge of aerosol and airway
clearance treatments (Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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4 Self management assessment
behaviours (Caregivers)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Self-management treatment
behaviour (Caregivers)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Self-management
communication behaviour
(Caregivers)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Self management responsiveness
to airway clearance treatment
when child unwell (Caregivers)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Self efficacy (Caregivers) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
8.1 post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 3. Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Appropriate self-management of
malabsorption (Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Inappropriate self-management
of malabsorption (Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Knowledge of nutrition and
enzymes (Children)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 Post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Appropriate self-management of
malabsorption (Caregivers)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 Post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Inappropriate self-management
of malabsorption (Caregivers)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 Post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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5.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Knowledge of malabsorption
and vitamins (Caregivers)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 Post test 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 4. General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Per cent predicted FEV1 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Weight 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Dietary fat intake 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Self efficacy 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Knowledge of cystic fibrosis
disease-specific nutrition
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Knowledge of general nutrition 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 6 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 12 months follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Analysis 1.1. Comparison 1 Self-management training versus standard treatment, Outcome 1 Change in
weight (Children).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 1 Change in weight (Children)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD)[pounds] N Mean(SD)[pounds] IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 94.39 (31.51) 10 102.13 (31.09) -7.74 [ -35.18, 19.70 ]
-50 -25 0 25 50
Favours training Favours control
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Analysis 1.2. Comparison 1 Self-management training versus standard treatment, Outcome 2 Number of
digestive system self-management behaviours (Children).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 2 Number of digestive system self-management behaviours (Children)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 11.1 (5.26) 10 16.4 (3.72) -5.30 [ -9.29, -1.31 ]
-10 -5 0 5 10
Favours control Favours training
Analysis 1.3. Comparison 1 Self-management training versus standard treatment, Outcome 3 Number of
pulmonary system self-management behaviours (Children).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 3 Number of pulmonary system self-management behaviours (Children)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 13.7 (7.15) 10 14.7 (4.72) -1.00 [ -6.31, 4.31 ]
-10 -5 0 5 10
Favours training Favours control
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Analysis 1.4. Comparison 1 Self-management training versus standard treatment, Outcome 4 Frequency of
digestive system self-management behaviours (Children).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 4 Frequency of digestive system self-management behaviours (Children)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 1.89 (0.84) 10 2.24 (0.76) -0.35 [ -1.05, 0.35 ]
-2 -1 0 1 2
Favours control Favours training
Analysis 1.5. Comparison 1 Self-management training versus standard treatment, Outcome 5 Frequency of
pulmonary system self-management behaviours (Children).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 5 Frequency of pulmonary system self-management behaviours (Children)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 1.56 (0.82) 10 1.84 (0.58) -0.28 [ -0.90, 0.34 ]
-1 -0.5 0 0.5 1
Favours training Favours control
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Analysis 1.6. Comparison 1 Self-management training versus standard treatment, Outcome 6 Total
frequency of digestive and pulmonary self-management behaviours (Children).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 6 Total frequency of digestive and pulmonary self-management behaviours (Children)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 1.84 (0.84) 10 2.02 (0.58) -0.18 [ -0.81, 0.45 ]
-1 -0.5 0 0.5 1
Favours training Favours control
Analysis 1.7. Comparison 1 Self-management training versus standard treatment, Outcome 7 Adherence -
percentage of prescribed medications taken by children.
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 7 Adherence - percentage of prescribed medications taken by children
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 87 (12) 10 85 (27) 2.00 [ -16.31, 20.31 ]
-20 -10 0 10 20
Favours control Favours training
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Analysis 1.8. Comparison 1 Self-management training versus standard treatment, Outcome 8 Adherence -
percentage of prescribed aerosol treatment taken by children.
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 8 Adherence - percentage of prescribed aerosol treatment taken by children
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 74 (33) 10 61 (42) 13.00 [ -20.11, 46.11 ]
-50 -25 0 25 50
Favours control Favours training
Analysis 1.9. Comparison 1 Self-management training versus standard treatment, Outcome 9 Adherence -
percentage of prescribed chest physiotherapy treatment taken by children.
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 9 Adherence - percentage of prescribed chest physiotherapy treatment taken by children
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 49 (43) 10 57 (44) -8.00 [ -46.13, 30.13 ]
-50 -25 0 25 50
Favours training Favours control
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Analysis 1.10. Comparison 1 Self-management training versus standard treatment, Outcome 10 Knowledge
of cystic fibrosis and its management (Children).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 10 Knowledge of cystic fibrosis and its management (Children)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 81.44 (9.26) 10 62.19 (16.42) 19.25 [ 7.57, 30.93 ]
-50 -25 0 25 50
Favours control Favours training
Analysis 1.11. Comparison 1 Self-management training versus standard treatment, Outcome 11 Quality of
well-being (Children).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 11 Quality of well-being (Children)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 0.71 (0.105) 10 0.73 (0.055) -0.02 [ -0.09, 0.05 ]
-0.2 -0.1 0 0.1 0.2
Favours control Favours training
46Self-management education for cystic fibrosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.12. Comparison 1 Self-management training versus standard treatment, Outcome 12 Number of
digestive system self-management behaviours (Parents).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 12 Number of digestive system self-management behaviours (Parents)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 16.8 (2.25) 10 17.8 (3.29) -1.00 [ -3.47, 1.47 ]
-4 -2 0 2 4
Favours training Favours control
Analysis 1.13. Comparison 1 Self-management training versus standard treatment, Outcome 13 Number of
pulmonary system self-management behaviours (Parents).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 13 Number of pulmonary system self-management behaviours (Parents)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 21.7 (3.43) 10 21.3 (3.71) 0.40 [ -2.73, 3.53 ]
-4 -2 0 2 4
Favours control Favours training
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Analysis 1.14. Comparison 1 Self-management training versus standard treatment, Outcome 14 Total
number of digestive and pulmonary self-management behaviours (Parents).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 14 Total number of digestive and pulmonary self-management behaviours (Parents)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 38.5 (4.17) 10 39.1 (6.14) -0.60 [ -5.20, 4.00 ]
-10 -5 0 5 10
Favours training Favours control
Analysis 1.15. Comparison 1 Self-management training versus standard treatment, Outcome 15 Frequency
of digestive system self-management behaviours (Parents).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 15 Frequency of digestive system self-management behaviours (Parents)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 2.73 (0.48) 10 2.82 (0.77) -0.09 [ -0.65, 0.47 ]
-2 -1 0 1 2
Favours training Favours control
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Analysis 1.16. Comparison 1 Self-management training versus standard treatment, Outcome 16 Frequency
of pulmonary system self-management behaviours (Parents).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 16 Frequency of pulmonary system self-management behaviours (Parents)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 2.7 (0.58) 10 2.68 (0.49) 0.02 [ -0.45, 0.49 ]
-1 -0.5 0 0.5 1
Favours control Favours training
Analysis 1.17. Comparison 1 Self-management training versus standard treatment, Outcome 17 Total
frequency of digestive and pulmonary system self-management behaviours (Parents).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 17 Total frequency of digestive and pulmonary system self-management behaviours (Parents)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 2.74 (0.42) 10 2.74 (0.57) 0.0 [ -0.44, 0.44 ]
-1 -0.5 0 0.5 1
Favours training Favours control
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Analysis 1.18. Comparison 1 Self-management training versus standard treatment, Outcome 18 Knowledge
of cystic fibrosis and its management (Parents).
Review: Self-management education for cystic fibrosis
Comparison: 1 Self-management training versus standard treatment
Outcome: 18 Knowledge of cystic fibrosis and its management (Parents)
Study or subgroup Training Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 to 8 weeks follow-up
Cottrell 1996 10 72.09 (11.64) 10 69.98 (8.01) 2.11 [ -6.65, 10.87 ]
-20 -10 0 10 20
Favours training Favours control
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Analysis 2.1. Comparison 2 Self-management education on aerosol and airway clearance treatments
(’Airways’) versus standard treatment, Outcome 1 Adherence - percentage of prescribed aerosol treatment
taken by children.
Review: Self-management education for cystic fibrosis
Comparison: 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus standard treatment
Outcome: 1 Adherence - percentage of prescribed aerosol treatment taken by children
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 post test
Downs 2006 18 100.6 (24.4) 25 70.9 (26.8) 29.70 [ 14.29, 45.11 ]
2 6 months follow-up
Downs 2006 18 98.5 (22.6) 25 77.5 (28.9) 21.00 [ 5.59, 36.41 ]
3 12 months follow-up
Downs 2006 18 91.7 (15.8) 25 74.2 (24.3) 17.50 [ 5.50, 29.50 ]
-50 -25 0 25 50
Favours control Favours Airways
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Analysis 2.2. Comparison 2 Self-management education on aerosol and airway clearance treatments
(’Airways’) versus standard treatment, Outcome 2 Adherence - percentage of airway clearance treatments
taken by children.
Review: Self-management education for cystic fibrosis
Comparison: 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus standard treatment
Outcome: 2 Adherence - percentage of airway clearance treatments taken by children
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 post test
Downs 2006 18 103.8 (24) 25 84.8 (41.3) 19.00 [ -0.62, 38.62 ]
2 6 months follow-up
Downs 2006 18 103 (18.6) 25 81.4 (30) 21.60 [ 7.04, 36.16 ]
3 12 months follow-up
Downs 2006 18 99.1 (33.4) 25 84 (25) 15.10 [ -3.18, 33.38 ]
-50 -25 0 25 50
Favours control Favours Airways
Analysis 2.3. Comparison 2 Self-management education on aerosol and airway clearance treatments
(’Airways’) versus standard treatment, Outcome 3 Knowledge of aerosol and airway clearance treatments
(Children).
Review: Self-management education for cystic fibrosis
Comparison: 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus standard treatment
Outcome: 3 Knowledge of aerosol and airway clearance treatments (Children)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 post test
Downs 2006 18 16.3 (2.4) 25 12.5 (2.6) 3.80 [ 2.29, 5.31 ]
2 12 months follow-up
Downs 2006 18 17.8 (3) 25 13.2 (2.8) 4.60 [ 2.83, 6.37 ]
-10 -5 0 5 10
Favours control Favours Airways
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Analysis 2.4. Comparison 2 Self-management education on aerosol and airway clearance treatments
(’Airways’) versus standard treatment, Outcome 4 Self management assessment behaviours (Caregivers).
Review: Self-management education for cystic fibrosis
Comparison: 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus standard treatment
Outcome: 4 Self management assessment behaviours (Caregivers)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 post test
Downs 2006 18 0.87 (0.18) 25 0.7 (0.31) 0.17 [ 0.02, 0.32 ]
2 6 months follow-up
Downs 2006 18 0.82 (0.22) 25 0.67 (0.3) 0.15 [ -0.01, 0.31 ]
3 12 months follow-up
Downs 2006 18 0.85 (0.17) 25 0.77 (0.31) 0.08 [ -0.06, 0.22 ]
-0.5 -0.25 0 0.25 0.5
Favours control Favours Airways
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Analysis 2.5. Comparison 2 Self-management education on aerosol and airway clearance treatments
(’Airways’) versus standard treatment, Outcome 5 Self-management treatment behaviour (Caregivers).
Review: Self-management education for cystic fibrosis
Comparison: 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus standard treatment
Outcome: 5 Self-management treatment behaviour (Caregivers)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 post test
Downs 2006 18 0.96 (0.11) 25 0.89 (0.16) 0.07 [ -0.01, 0.15 ]
2 6 months follow-up
Downs 2006 18 0.99 (0.03) 25 0.87 (0.15) 0.12 [ 0.06, 0.18 ]
3 12 months follow-up
Downs 2006 18 0.95 (0.1) 25 0.91 (0.16) 0.04 [ -0.04, 0.12 ]
-0.2 -0.1 0 0.1 0.2
Favours control Favours Airways
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Analysis 2.6. Comparison 2 Self-management education on aerosol and airway clearance treatments
(’Airways’) versus standard treatment, Outcome 6 Self-management communication behaviour (Caregivers).
Review: Self-management education for cystic fibrosis
Comparison: 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus standard treatment
Outcome: 6 Self-management communication behaviour (Caregivers)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 post test
Downs 2006 18 0.81 (0.23) 25 0.52 (0.31) 0.29 [ 0.13, 0.45 ]
2 6 months follow-up
Downs 2006 18 0.72 (0.29) 25 0.52 (0.27) 0.20 [ 0.03, 0.37 ]
3 12 months follow-up
Downs 2006 18 0.66 (0.26) 25 0.55 (0.31) 0.11 [ -0.06, 0.28 ]
-0.5 -0.25 0 0.25 0.5
Favours control Favours airways
Analysis 2.7. Comparison 2 Self-management education on aerosol and airway clearance treatments
(’Airways’) versus standard treatment, Outcome 7 Self management responsiveness to airway clearance
treatment when child unwell (Caregivers).
Review: Self-management education for cystic fibrosis
Comparison: 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus standard treatment
Outcome: 7 Self management responsiveness to airway clearance treatment when child unwell (Caregivers)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 post test
Downs 2006 14 0.61 (0.39) 10 0.38 (0.37) 0.23 [ -0.08, 0.54 ]
-0.5 -0.25 0 0.25 0.5
Favours control Favours Airways
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Analysis 2.8. Comparison 2 Self-management education on aerosol and airway clearance treatments
(’Airways’) versus standard treatment, Outcome 8 Self efficacy (Caregivers).
Review: Self-management education for cystic fibrosis
Comparison: 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus standard treatment
Outcome: 8 Self efficacy (Caregivers)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 post test
Downs 2006 18 4.16 (0.52) 25 4.1 (0.51) 0.06 [ -0.25, 0.37 ]
2 6 months follow-up
Downs 2006 18 4.3 (0.5) 25 4.07 (0.54) 0.23 [ -0.08, 0.54 ]
3 12 months follow-up
Downs 2006 18 4.44 (0.34) 25 4.19 (0.5) 0.25 [ 0.00, 0.50 ]
-0.5 -0.25 0 0.25 0.5
Favours control Favours Airways
Analysis 3.1. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard
treatment, Outcome 1 Appropriate self-management of malabsorption (Children).
Review: Self-management education for cystic fibrosis
Comparison: 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment
Outcome: 1 Appropriate self-management of malabsorption (Children)
Study or subgroup Favours control Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Post test
Stapleton 2001 21 13.7 (3.2) 21 13.1 (3.2) 0.60 [ -1.34, 2.54 ]
2 12 months follow-up
Stapleton 2001 21 12.3 (2.74) 20 12.8 (2.68) -0.50 [ -2.16, 1.16 ]
-10 -5 0 5 10
Favours control Favours Go and Grow
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Analysis 3.2. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard
treatment, Outcome 2 Inappropriate self-management of malabsorption (Children).
Review: Self-management education for cystic fibrosis
Comparison: 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment
Outcome: 2 Inappropriate self-management of malabsorption (Children)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Post test
Stapleton 2001 21 2.7 (1.37) 21 1.9 (0.91) 0.80 [ 0.10, 1.50 ]
2 12 months follow-up
Stapleton 2001 21 2.3 (1.83) 20 1.9 (1.34) 0.40 [ -0.58, 1.38 ]
-2 -1 0 1 2
Favours control Favours Go and Grow
57Self-management education for cystic fibrosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.3. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard
treatment, Outcome 3 Knowledge of nutrition and enzymes (Children).
Review: Self-management education for cystic fibrosis
Comparison: 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment
Outcome: 3 Knowledge of nutrition and enzymes (Children)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Post test
Stapleton 2001 21 27.5 (5.03) 21 24.4 (5.03) 3.10 [ 0.06, 6.14 ]
2 12 months follow-up
Stapleton 2001 21 25.5 (5.49) 20 25.8 (5.17) -0.30 [ -3.56, 2.96 ]
-4 -2 0 2 4
Favours control Favours Go and Grow
Analysis 3.4. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard
treatment, Outcome 4 Appropriate self-management of malabsorption (Caregivers).
Review: Self-management education for cystic fibrosis
Comparison: 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment
Outcome: 4 Appropriate self-management of malabsorption (Caregivers)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Post test
Stapleton 2001 27 47.2 (2.59) 28 46.8 (2.64) 0.40 [ -0.98, 1.78 ]
2 12 months follow-up
Stapleton 2001 27 48 (3.63) 27 48 (2.59) 0.0 [ -1.68, 1.68 ]
-10 -5 0 5 10
Favours experimental Favours Go and Grow
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Analysis 3.5. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard
treatment, Outcome 5 Inappropriate self-management of malabsorption (Caregivers).
Review: Self-management education for cystic fibrosis
Comparison: 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment
Outcome: 5 Inappropriate self-management of malabsorption (Caregivers)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Post test
Stapleton 2001 27 13.7 (0.51) 28 13.1 (5.29) 0.60 [ -1.37, 2.57 ]
2 12 months follow-up
Stapleton 2001 27 12.6 (6.22) 27 13.4 (4.67) -0.80 [ -3.73, 2.13 ]
-10 -5 0 5 10
Favours control Favours Go and Grow
Analysis 3.6. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard
treatment, Outcome 6 Knowledge of malabsorption and vitamins (Caregivers).
Review: Self-management education for cystic fibrosis
Comparison: 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment
Outcome: 6 Knowledge of malabsorption and vitamins (Caregivers)
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Post test
Stapleton 2001 27 37.2 (3.11) 28 37.1 (3.17) 0.10 [ -1.56, 1.76 ]
2 12 months follow-up
Stapleton 2001 27 37 (3.11) 27 37.6 (2.59) -0.60 [ -2.13, 0.93 ]
-10 -5 0 5 10
Favours control Favours Go and Grow
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Analysis 4.1. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus
standard treatment, Outcome 1 Per cent predicted FEV1.
Review: Self-management education for cystic fibrosis
Comparison: 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment
Outcome: 1 Per cent predicted FEV1
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months follow-up
Watson 2008 23 54.9 (25.1) 25 59.9 (20.8) -5.00 [ -18.10, 8.10 ]
2 12 months follow-up
Watson 2008 23 52.8 (24.1) 25 58.3 (21.5) -5.50 [ -18.46, 7.46 ]
-100 -50 0 50 100
Favours Eat well with CF Favours control
Analysis 4.2. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus
standard treatment, Outcome 2 Weight.
Review: Self-management education for cystic fibrosis
Comparison: 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment
Outcome: 2 Weight
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD)[Kilograms] N Mean(SD)[Kilograms] IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months follow-up
Watson 2008 23 59.5 (10) 25 60.2 (10.8) -0.70 [ -6.58, 5.18 ]
2 12 months follow-up
Watson 2008 23 59.9 (9.7) 25 60.6 (11.2) -0.70 [ -6.62, 5.22 ]
-10 -5 0 5 10
Favours control Favours eat well with CF
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Analysis 4.3. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus
standard treatment, Outcome 3 Dietary fat intake.
Review: Self-management education for cystic fibrosis
Comparison: 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment
Outcome: 3 Dietary fat intake
Study or subgroup Intervention Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months follow-up
Watson 2008 23 33.7 (9.4) 25 32.1 (6) 1.60 [ -2.90, 6.10 ]
2 12 months follow-up
Watson 2008 23 32.4 (8.8) 25 32.2 (5.9) 0.20 [ -4.08, 4.48 ]
-10 -5 0 5 10
Favours control Favours Eat well with CF
Analysis 4.4. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus
standard treatment, Outcome 4 Self efficacy.
Review: Self-management education for cystic fibrosis
Comparison: 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment
Outcome: 4 Self efficacy
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months follow-up
Watson 2008 23 21.9 (4.4) 25 17.7 (5.1) 4.20 [ 1.51, 6.89 ]
2 12 months follow-up
Watson 2008 23 22.6 (5.2) 25 19.3 (4.4) 3.30 [ 0.56, 6.04 ]
-10 -5 0 5 10
Favours control Favours Eat well with CF
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Analysis 4.5. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus
standard treatment, Outcome 5 Knowledge of cystic fibrosis disease-specific nutrition.
Review: Self-management education for cystic fibrosis
Comparison: 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment
Outcome: 5 Knowledge of cystic fibrosis disease-specific nutrition
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months follow-up
Watson 2008 23 42.7 (3.9) 25 37.5 (5.2) 5.20 [ 2.61, 7.79 ]
2 12 months follow-up
Watson 2008 23 41.8 (4.9) 25 38.9 (6.1) 2.90 [ -0.22, 6.02 ]
-10 -5 0 5 10
Favours control Favours Eat well with CF
Analysis 4.6. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus
standard treatment, Outcome 6 Knowledge of general nutrition.
Review: Self-management education for cystic fibrosis
Comparison: 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment
Outcome: 6 Knowledge of general nutrition
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months follow-up
Watson 2008 23 11.6 (2.9) 25 10.9 (3.8) 0.70 [ -1.20, 2.60 ]
2 12 months follow-up
Watson 2008 23 12.1 (2.6) 25 11.2 (3.8) 0.90 [ -0.93, 2.73 ]
-4 -2 0 2 4
Favours control Favours Eat well with CF
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A D D I T I O N A L T A B L E S
Table 1. Summary of the Effects of Interventions
Self-management training programme versus standard treatment (Cottrell 1996)
Effects of intervention
(Statistically significant results favouring intervention group are presented in bold)
PRIMARY OUTCOME (Children)
Indices of nutritional health or growth
Change in weight
Assessment time points : 6- to 8-weeks follow up
No statistically significant difference between groups in change in weight: MD -7.74 lb
(95% CI -35.18 to 19.70) (in kg this is equivalent to: MD 3.51 kg (95% CI -15.96 to
8.94) (Analysis 1.1).
SECONDARY OUTCOMES (Children)
Self-management behaviours
Number of digestive and pulmonary system
behaviours
Frequency of digestive and pulmonary system
behaviours
Assessment time points : 6- to 8-weeks follow up
Statistically significantly greater number of digestive behaviours in the standard treatment
group than training group, MD -5.30 (95% CI -9.29 to -1.31) (Analysis 1.2). No
statistically significant difference between groups in the number of pulmonary system
behaviours, MD -1.00 (95% CI -6.31 to 4.31) (Analysis 1.3).
No statistically significant differences between groups for digestive system, pulmonary
system, or both systems combined, MD -0.35 (95% CI -1.05 to 0.35); MD -0.28 (95%
CI -0.90 to 0.34); and MD -0.18 (95% CI -0.81 to 0.45) respectively (Analysis 1.4;
Analysis 1.5; Analysis 1.6)
Adherence
Percentages of medications, aerosol treat-
ments, and chest physiotherapy taken.
Assessment time points : 6- to 8- weeks follow up
No statistically significant differences between groups in the % of prescribed treatments
takenby children:medicationsMD2.00%(95%CI -16.31 to 20.31); aerosol treatments,
MD 13.00% (95% CI -20.11 to 46.11), and chest physiotherapy, MD -8.00 % (95%
CI -46.13 to 30.13) (Analysis 1.7; Analysis 1.8; Analysis 1.9).
Knowledge Assessment time points: 6- to 8-weeks follow up
Statsitically significant greater knowledge scores about CF and its management in the
training group than the standard treatment groups, MD 19.25% (95% CI 7.57 to 30.
93) (Analysis 1.10).
Health-related quality of life
Quality of well-being
Assessment time points: 6- to 8-weeks follow up
No statistically significant difference between groups, MD -0.02 (95% CI -0.09 to 0.
05) (Analysis 1.11).
SECONDARY OUTCOMES (Parents)
Self-management behaviours
Number of digestive and pulmonary system
behaviours
Frequency of digestive and pulmonary system
behaviours
Assessment time points : 6- to 8-weeks follow up
No statistically significant differences between groups for digestive system, pulmonary
system, or both systems combined, MD -1.00 (95% CI -3.47 to 1.47), MD 0.40 (95%
CI -2.73 to 3.53), and MD -0.60 (95% CI -5.20 to 4.00) respectively (Analysis 1.12;
Analysis 1.13; Analysis 1.14).
No statistically significant differences between groups for digestive system, pulmonary
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Table 1. Summary of the Effects of Interventions (Continued)
system, or both systems combined, MD -0.09 (95% CI -0.65 to 0.47); MD 0.02 (95%
CI -0.45 to 0.49); and MD 0.00 (95% CI -0.44 to 0.44) respectively (Analysis 1.15;
Analysis 1.16; Analysis 1.17).
Knowledge Assessment time points: 6- to 8-weeks follow up
No statistically significant difference between groups, MD 2.11% (95% CI -6.65 to 10.
87) (Analysis 1.18).
Self-management education on aerosol and airway treatment clearance education (’Airways’) versus standard treatment (Downs
2006).
Effects of intervention
(Statistically significant results favouring intervention group are presented in bold)
SECONDARY OUTCOMES (Children)
Adherence Assessment time points : Post test, 6-months follow up, 12-months follow up
Statistically significant greater % of prescribed aerosol treatments taken by ’Airways’
group at each time point (Analysis 2.1): Post testMD 29.70% (95% CI 14.29 to 45.
11); 6-months follow upMD 21.00% (95% CI 5.59 to 36.41); 12-months follow up
MD 17.50% (95% CI 5.50 to 29.50) .
Statistically significant greater % of prescribed airway clearance treatments taken by
’Airways’ group significantly greater at 6-months follow-up only (Analysis 2.2): Post test
MD 19.00% (95% CI -0.62 to 38.62); 6-months follow upMD 21.60% (CI 95% 7.
04 to 36.16); 12-months follow upMD 15.10% (95% CI -3.18 to 33.38).
Knowledge Assessment time points : Post test, 12-months follow up
Significantly greater knowledge scores in the ’Airways’ group at each time point (Analysis
2.3): Post testMD 3.80 (95% CI 2.29 to 5.31); 12-months follow upMD 4.60 (95%
CI 2.83 to 6.37).
SECONDARY OUTCOMES (Caregivers)
Self-management behaviours
Assessment behaviour
Treatment behaviour
Communication behaviour
Responsiveness to airway clearance treatments
on children’s unwell days
Self-efficacy to manage airway clearance
treatments
Assessment time points : Post test, 6-months follow up, 12-months follow up
Statistically significant greater assessment behaviour scores in the ’Airways’ group post
test only (Analysis 2.4): Post test MD 0.17 (95% CI 0.02 to 0.32); 6-months follow
up MD 0.15 (95% CI -0.01 to 0.31); 12-months follow up MD 0.08 (95% CI -0.06
to 0.22).
Statistically significant greater treatment behaviour scores in the ’Airways’ group at 6
month only (Analysis 2.5): Post test MD 0.07 (95% CI -0.01 to 0.15); 6-months follow
upMD 0.12 (95% CI 0.06 to 0.18); 12-months follow upMD 0.04 (95% CI -0.04 to
0.12).
Statistically significant greater communication behaviour scores in the ’Airways’ group
at post test and 6 months (Analysis 2.6): Post test, MD 0.29 (95% CI 0.13 to, 0.45);
6-months follow upMD 0.20 (95% CI 0.03 to 0.37); 12-months follow up MD 0.11
(95% CI -0.06 to 0.28).
No statistically significant difference between groups in responsiveness (Analysis 2.7):
Post test MD 0.23 (95% CI -0.08 to 0.54) (not assessed at 6- or 12-month follow ups)
No statistically significant differences between groups in self-efficacy (Analysis 2.8): Post
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Table 1. Summary of the Effects of Interventions (Continued)
test MD 0.06 (95% CI -0.25 to 0.37); 6-months follow up MD 0.23 (95% CI -0.08 to
0.54); 12-months follow up MD 0.25 (95% CI -0.00 to 0.50).
Nutrition self-management education versus standard treatment
i. Sub-comparison: Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment (Stapleton 2001)
.
Effects of intervention (Statistically sig-
nificant results favouring intervention
group are presented in bold)
SECONDARY OUTCOMES (Children)
Self-management behaviours
Appropriateness of nutrition and enzyme self-
management
Assessment time points : Post test, 12-months follow up
No statistically significant differences between groups in changes in nutrition and enzyme
appropriate self-management response scores (Analysis 3.1): Post test MD 0.60 (95%
CI -1.34 to 2.54); 12-months follow up MD -0.50 (95% CI -2.16 to 1.16).
Statistically significant lower inappropriate nutrition and enzyme inappropriate self-
management response score in the ’Go and Grow’ group at post test only (Analysis 3.2)
: Post testMD 0.80 (95% CI 0.10 to 1.50); 12-months follow up MD 0.40 (95% CI
-0.58 to 1.38).
Knowledge Assessment time points : Post test, 12-months follow up
Statistically significant greater nutrition knowledge scores in the ’Go and Grow’ group
at post test only (Analysis 3.3): Post testMD 3.10 (95% CI 0.06 to 6.14); 12-months
follow upMD -0.30 (95% CI -3.56 to 2.96).
SECONDARY OUTCOMES (Caregivers)
Self-management behaviours
Appropriateness of nutrition and enzyme self-
management
Assessment time points : Post test, 12-months follow up
No statistically significant differences between groups in nutrition and enzyme appro-
priate self-management response scores (Analysis 3.4): Post test MD 0.40 (95% CI -0.
98 to 1.78); 12-months follow up MD 0.00 (95% CI -1.68 to 1.68).
No statistically significant differences between groups in nutrition and enzyme inappro-
priate self-management response scores (Analysis 3.5): Post test MD 0.60 (95% CI -1.
37 to 2.57);12-months follow up MD -0.80 (95% CI -3.73 to 2.13).
Knowledge Assessment time points : Post test, 12-months follow up
No statistically significant differences between groups in nutrition knowledge scores
(Analysis 3.6): Post test MD 0.10 (95% CI -1.56 to 1.76); 12-months follow up MD -
0.60 (95% CI -2.13 to 0.93).
ii. Sub-comparison: General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment (Watson 2008)
Effects of intervention
(Statistically significant results favouring intervention group are presented in bold)
PRIMARY OUTCOME (Adults)
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Table 1. Summary of the Effects of Interventions (Continued)
Pulmonary Function
FEV1
Assessment time points : 6-months follow up, 12-months follow up
No statistically significant differences between groups in per cent predicted FEV1 (
Analysis 4.1): 6-months follow up MD -5.00 % (95% CI -18.10 to 8.10); 12-months
follow up MD -5.50 % (95% CI -18.46 to 7.46).
Indices of nutritional health or growth
Change in weight
Dietary fat intake
Assessment time points : 6-months follow-up, 12-months follow up
No statistically significant differences between groups in changes in weight (Analysis 4.2)
: 6-months follow up MD - 0.70 kg (95% C1 -6.58 to 5.18); 12-months follow upMD
-0.70 kg (95% C1 -6.62 to 5.22).
No statistically significant differences between groups in self-reported dietary fat intake
scores (Analysis 4.3): 6-months follow upMD 1.60 (85% C1-2.90 to 6.10); 12-months
follow up MD 0.20 (95% CI -4.08 to 4.48).
SECONDARY OUTCOMES (Adults)
Self-management behaviour
Self-efficacy
Assessment time points : 6-months follow-up, 12-months follow up
Statistically significant greater self-efficacy scores in the ’Eat Well with CF’ group (
Analysis 4.4):6-months follow upMD 4.20 (95% CI 1.51 to 6.89); 12-months follow
upMD 3.30 (95% CI 0.56 to 6.04).
Knowledge
Disease-specific nutrition knowledge
General nutrition knowledge
Assessment time points : 6-months follow up, 12-months follow up
Statistically significant greater disease-specific nutrition knowledge scores in the ’EatWell
with CF’ group at 6 months only (Analysis 4.5): 6-months follow up MD 5.20 (95%
CI 2.61 to 7.79); 12-months follow up MD 2.90 (95% CI -0.22 to 6.02).
No statistically significant differences between groups in general nutrition knowledge
scores (Analysis 4.6): 6-months follow upMD 0.70 (95% CI -1.20 to 2.60); 12-months
follow up MD 0.90 (95% CI -09.93 to 2.73).
Health-related quality of life Data for analysis in the format required for the review could not be extracted from
published papers or unpublished data available on this trial
CF: cystic fibrosis
CI: confidence intervals
FEV1: forced expiratory volume at one second
kg: kilogram
lb: pound
MD: mean difference
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A P P E N D I C E S
Appendix 1. Search Strategy: CINAHL with Full Text (EBSCO)
Date of Search 02 February 2014
Years Covered January 1990 to January 2014
Complete Strategy 1. cystic fibrosis.TX.
2. mucoviscidosis.TX.
3. 1 or 2
4. clinical trial.PT.
5. trial.TX.
6. random*TX.
7. 4 or 5 or 6
8. educat*.TX.
9. program*TX.
10. 8 or 9
11. self care.TX.
12. self-care.TX.
13. selfcare. TX.
14. self management. TX.
15. self-management.TX.
16. manag*.TX.
17. 11 or 12 or 13 or 14 or 15 or 16
18. 10 or 17
19. 3 and 7 and 18
Language Restrictions None
Appendix 2. Search Strategy: Psychological and Behavioural Sciences Collection (EBSCO)
Date of Search 02 February 2014
Years Covered January 1990 to January 2014
Complete Strategy 1. cystic fibrosis.TX.
2. mucoviscidosis.TX.
3. 1 or 2
4. clinical trial.PT.
5. trial.TX.
6. random*TX.
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7. 4 or 5 or 6
8. educat*.TX.
9. program*TX.
10. 8 or 9
11. self care.TX.
12. self-care.TX.
13. selfcare. TX.
14. self management. TX.
15. self-management.TX.
16. manag*.TX.
17. 11 or 12 or 13 or 14 or 15 or 16
18. 10 or 17
19. 3 and 7 and 18
Language Restrictions None
Appendix 3. Search Strategy: PsychoInfo (EBSCO)
Date of Search 02 February 2014
Years Covered January 1990 to January 2014
Complete Strategy 1. cystic fibrosis.TX.
2. mucoviscidosis.TX.
3. 1 or 2
4. clinical trial.PT.
5. trial.TX.
6. random*TX.
7. 4 or 5 or 6
8. educat*.TX.
9. program*TX.
10. 8 or 9
11. self care.TX.
12. self-care.TX.
13. selfcare. TX.
14. self management. TX.
15. self-management.TX.
16. manag*.TX.
17. 11 or 12 or 13 or 14 or 15 or 16
18. 10 or 17
19. 3 and 7 and 18
Language Restrictions None
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Appendix 4. Search Strategy: SocINDEX (EBSCO)
Date of Search 03 February 2014
Years Covered January 1990 to January 2014
Complete Strategy 1. cystic fibrosis.TX.
2. mucoviscidosis.TX.
3. 1 or 2
4. clinical trial.PT.
5. trial.TX.
6. random*TX.
7. 4 or 5 or 6
8. educat*.TX.
9. program*TX.
10. 8 or 9
11. self care.TX.
12. self-care.TX.
13. selfcare. TX.
14. self management. TX.
15. self-management.TX.
16. manag*.TX.
17. 11 or 12 or 13 or 14 or 15 or 16
18. 10 or 17
19. 3 and 7 and 18
Language Restrictions None
Appendix 5. Search Strategy: Embase (Elsevier)
Date of Search 03 February 2014
Years Covered January 1990 to January 2014
Complete Strategy 1. cystic fibrosis. ti,ab,de.
2. mucoviscidosis. ti,ab,de.
3. 1 or 2
4. ’clinical trial’. ti,ab,de.
5. ’trial’. ti,ab,de.
6. random*’. ti,ab,de.
7. 4 or 5 or 6
8. educat*. ti, ab, de.
9. program*. ti,ab,de.
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10. 8 or 9
11. self care ti, ab, de.
12. selfcare. ti,ab,de.
13. self management. ti, ab,de
14. manag*. ti, ab,de.
15. 11 or 12 or 13 or 14
16. 10 or 15
17. 3 and 7 and 16
Language Restrictions None
WH A T ’ S N E W
Last assessed as up-to-date: 25 July 2014.
Date Event Description
25 July 2014 New citation required but conclusions have not changed New citations have been added to studies excluded, ongo-
ing or awaiting classification. No new studies have been
added to the ’Included studies’ section of the review.
25 July 2014 New search has been performed New searches have been carried out for this review update.
H I S T O R Y
Protocol first published: Issue 1, 2009
Review first published: Issue 7, 2011
Date Event Description
25 April 2007 New citation required and major changes Substantive amendment
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C O N T R I B U T I O N S O F A U T H O R S
E Savage: conception and design of the review, coordinating the review, writing the protocol, search strategy development, undertaking
searches and retrievingpapers for the review, screening retrieved papers against the inclusion criteria, extractingdata from includedpapers,
appraising quality of papers, writing to authors of papers for additional information, data analysis and interpretation, data management
for the review, entering data into RevMan, writing the review, sourcing funding for the review, taking principal responsibility for
updating the review.
P Beirne: design of review, critically evaluating protocol, screening retrieved papers against inclusion criteria, appraising quality of
papers, data interpretation, providing general advice on the conducting a systematic review.
D Farrell: assisted with search strategy and with retrieval of papers. Cross-checked data extraction. Cross-checked data entry of results
for each outcome to Revman against published papers and data extraction form. Providing administrative and technical support for all
aspects of the review.
M Ni Chronin: providing clinical advice on disease management of cystic fibrosis, critically evaluating protocol, providing general
advice on the review and interpretation of results.
A Duff: providing advice on self-management education interventions for patients with cystic fibrosis, critically evaluating protocol,
providing general advice on the review and interpretation of results.
T Fitzgerald: providing statistical support for data analysis and interpretation.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• University College Cork, Ireland.
External sources
• Health Research Board, Ireland.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Order of secondary outcomes changed to place health-related quality of life further down.
Search strategy was revised and appendices for each database searched are included.
The author Dawn Farrel has been added.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Self Care; Caregivers [education]; Cystic Fibrosis [∗therapy]; Nutrition Therapy; Parents [education]; Patient Education as Topic
[∗methods]; Randomized Controlled Trials as Topic
MeSH check words
Adolescent; Adult; Child; Humans; Young Adult
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